ArticlePDF Available

Shrimp disease management for sustainable aquaculture: innovations from nanotechnology and biotechnology

Authors:

Abstract and Figures

Infectious diseases in shrimp are one of the significant constraints in shrimp aquaculture across the globe. The alarming increase of antibiotic resistance in bacteria has rendered antibiotic therapy a controversial subject today. Therefore, the practice of antibiotic therapy in aquaculture needs to be dissuaded and appropriate alternatives have to be found out. For the past few decades, the field of nanotechnology and biotechnology has proposed novel and effective solutions involving the use of nanoparticles, biofilm-based vaccines, algal extracts, phytobiotics, probiotics, prebiotics, and synbiotics to combat infectious diseases. Algal extracts, phytobiotics, probiotics, prebiotics, and synbiotics are compounds of biological origin due to which they are safe to use in aquaculture settings. With the advent of green and bio-nanotechnology, nanomaterials are also becoming a safer alternative to antibiotic therapy. Vaccines developed from antigenic components of bacterial biofilms are more promising than regular vaccines synthesized from antigens of planktonic forms. Some of these methods have extended applications in shrimp aquaculture in the form of immunomodulants, diagnostic tools, drug and vaccine carriers. The hazards of chemotherapy in shrimp aquaculture can be overcome by replacing antibiotics and other chemical agents with these new approaches. Adopting these strategies makes aquaculture-based food more organic, consumer-friendly and helps in establishing sustainable aquaculture. This review reveals the ill effects of antibiotic therapy in shrimp aquaculture and casts light on the advantages and the research gaps in these strategies that need to be addressed. Graphical Abstract
This content is subject to copyright. Terms and conditions apply.
Shrimp disease management for sustainable
aquaculture: innovations
from nanotechnology and biotechnology
P.S Seethalakshmi
1
&Riya Rajeev
1
&George Seghal Kiran
2
&Joseph Selvin
1
Received: 7 December 2020 /Accepted: 19 March 2021 /
#The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021
Abstract Infectious diseases in shrimp are one of the significant constraints in shrimp
aquaculture across the globe. The alarming increase of antibiotic resistance in bacteria has
rendered antibiotic therapy a controversial subject today. Therefore, the practice of
antibiotic therapy in aquaculture needs to be dissuaded and appropriate alternatives have
to be found out. For the past few decades, the field of nanotechnology and biotechnology
has proposed novel and effective solutions involving the use of nanoparticles, biofilm-
based vaccines, algal extracts, phytobiotics, probiotics, prebiotics, and synbiotics to
combat infectious diseases. Algal extracts, phytobiotics, probiotics, prebiotics, and
synbiotics are compounds of biological origin due to which they are safe to use in
aquaculture settings. With the advent of green and bio-nanotechnology, nanomaterials
are also becoming a safer alternative to antibiotic therapy. Vaccines developed from
antigenic components of bacterial biofilms are more promising than regular vaccines
synthesized from antigens of planktonic forms. Some of these methods have extended
applications in shrimp aquaculture in the form of immunomodulants, diagnostic tools,
drug and vaccine carriers. The hazards of chemotherapy in shrimp aquaculture can be
overcome by replacing antibiotics and other chemical agents with these new approaches.
Adopting these strategies makes aquaculture-based food more organic, consumer-friendly
and helps in establishing sustainable aquaculture. This review reveals the ill effects of
antibiotic therapy in shrimp aquaculture and casts light on the advantages and the research
gaps in these strategies that need to be addressed.
Keywords Antibiotic resistance .Nanomaterials .Phage therapy .Phytobiotics .Probiotics .
Synbiotics
https://doi.org/10.1007/s10499-021-00698-2
Handling Editor: Brian Austin
*Joseph Selvin
josephselvinss@gmail.com; jselvin.mib@pondiuni.edu.in
1
Department of Microbiology, Pondicherry University, Puducherry 605014, India
2
Department of Food Science and Technology, Pondicherry University, Puducherry 605014, India
Published online: 14 April 2021
Aquaculture International (2021) 29:1591–1620
Introduction
Shrimp aquaculture is the practice of breeding, rearing, and harvesting of shrimp species in
man-made environments for human welfare. Shrimp is one of the most widely consumed
seafood around the world (FAO 2019). Considering the population increase, there is a massive
demand for shrimp-based food products and aquaculture plays a crucial role to meet them
(Kobayashi et al. 2015). The development of shrimp aquaculture has also decreased the
problems associated with overfishing in marine ecosystems (Pradhan and Flaherty 2007).
Greater acceptance of shrimp aquaculture at the global level animal-based food supply
indicates the necessity of sustainable development and extensive production of several shrimp
varieties (Rajeev et al. 2021).
Aquaculture practices have brought shrimp to artificial environments where they can
encounter various pathogens generally absent in their natural habitat (Nga et al. 2005).
Variations in pH of rearing water, temperature, dissolved oxygen content, and presence of
toxic chemicals are some of the commonly encountered physical and chemical factors that
contribute to poor growth and mortalities in shrimp (Nga et al. 2005). The chances of
infections emerge due to poor water quality and feed, which weakens the innate immunity
of shrimp. Mass mortalities in shrimp due to infections occur due to the transmission of
pathogens when densely stocked (Wiyoto et al. 2017). The exportation of farmed shrimp
commodities to many countries has also resulted in pandemics in aquaculture farms (Walker
and Mohan 2009). Diseases in aquaculture industries can be a threat for humans and other wild
aquatic species too, as pathogens can cross species barriers (Walker and Mohan 2009;Zhang
et al. 2018). Antibiotic therapy for disease prevention in shrimp aquaculture was initially a
huge success, until microorganisms started acquiring resistance against antibiotics. Antibiotic
resistance renders bacterial infections in shrimp recalcitrant to antibiotic therapy, and
antibiotic-resistant genes can get transmitted to nearby ecosystems, from shrimp farms. Human
pathogens receiving such antibiotic-resistant genes from aquaculture settings can challenge our
concurrent health system (Holmström et al. 2003). Hence, strategies safe for aquatic life,
humans, and the environment need to be implemented. Research in nanotechnology and
biotechnology have experimented and analyzed holistic approaches that serve as a potential
alternative to antibiotics in controlling infectious diseases in shrimp aquaculture. This review
deliberates the issues of antibiotic usage in the aquaculture sector and the benefits of
environment-friendly approaches such as algal extracts, phytobiotics, phages, biofilm-based
vaccines, probiotics, and synbiotics.
Infectious diseases and the advent of antimicrobial resistance in shrimp
aquaculture
Infectious diseases have affected shrimp aquaculture industries drastically, and the majority of
infections in cultured shrimp are of bacterial and viral origin with few important diseases of
protozoa and fungi (Lightner and Redman 1998). Acute hepatopancreatic necrosis disease
(AHPND), formerly known as early mortality syndrome (EMS), is a bacterial shrimp disease
due to the action of PirABvp toxin secreted by Vibrio parahaemolyticus. The outbreak of
AHPND has plagued the aquaculture industry with substantial economic losses since 2009
(Lai et al. 2015). AHPND can also be caused by other strains of Vibrios such as Vibrio
harveyi,Vibrio punensis,Vibrio owensii,Vibrio campbellii,andVibrio alginolyticus which
1592 Aquaculture International (2021) 29:1591–1620
possess pVA1-type plasmid where the genes encoding the toxin are located (Dong et al. 2019).
V. alginolyticus is an opportunistic pathogen of shrimp known to cause mortalities under
poor environmental conditions (Liu and Chen 2004). Vibrio harveyi, which causes lumi-
nous vibriosis, is another etiological agent for mass mortalities in Penaeid shrimp
(Karunasagar et al. 1994). White Spot Syndrome Virus (WSSV) and Infectious
Myonecrosis Virus (IMNV) are the other two most important viral pathogens affecting
shrimp aquaculture. WSSV is highly virulent and causes total mortality in shrimp within 3
to10 days after the appearance of clinical symptoms (Sánchez-Martínez et al. 2007). In
contrast, IMNV is less threatening as mortalities are reported under unfavorable physico-
chemical conditions (Prasad et al. 2017).
Shrimp larvae are particularly susceptible to mycosis caused by fungi such as
Saprolegnia parasitica and Achlya flagellate. The fungi enter larvae through antenna,
eyestalks and invade body tissues, ultimately leading to death (Hubschman and Schmitt
1969). Enterocytozoon hepatopenaei (EHP) is a microsporidian parasite that retards shrimp
growth (Rajendran et al. 2016) and often causes white feces syndrome (WFS) in cultured
shrimp (Tangprasittipap et al. 2013).
In comparison to wild-caught shrimp, antibiotic resistance is much more pronounced in
farmed shrimp, suggesting the unsystematic usage of antibiotics in shrimp farms for increasing
the yield of production (Boinapally and Jiang 2007). The choice of antimicrobials used in
farming practices is often based on the knowledge of shrimp farmers or chemical suppliers and
not from veterinary services (Chi et al. 2017; Ali et al. 2016). This is the main reason why
indiscriminate use of chemotherapeutic agents prevails in the aquaculture sector.
Previous studies have reported shrimp pathogens belonging to the Vibrio genera showing
resistance to antibiotics such as tetracycline and β-lactam antibiotics, from aquaculture settings
(Nakayama et al. 2006;Meloetal.2011; Albuquerque Costa et al. 2015). Karunasagar et al.
(1994) reported mass mortalities of shrimp larvae due to antibiotic-resistant Vibrio infections,
which suggests that antibiotic-resistant pathogens can be highly devastating. The source of
antibiotic-resistant strains in shrimp farms could be the seawater collected for rearing. Draining
antibiotics and other chemicals containing effluents into the sea may have contributed to the
emergence of antibiotic-resistant Vibrios in marine ecosystems (Srinivasan and Ramasamy
2009).
Plasmids in Vibrio have a considerable role in disseminating antibiotic-resistant genes to
other bacteria, making it a huge problem from the environmental perspective (Sengupta and
Austin 2011). It was experimentally demonstrated that the Vibrio strain HL60 could transfer
cephalothin resistant genes present in the plasmid to Escherichia coli (Molina-Aja et al. 2002).
Kitiyodom et al. (2010) found that integrons could transmit antibiotic resistance in multi-drug
resistant Vibrios isolated from shrimp farms of Thailand. Presence of antibiotic-resistant genes
and their dissemination in aquaculture sites is a clear indication of a threat to food safety (Su
et al. 2017). Antibiotic-resistant forms of food-borne pathogens such as Salmonella (Banerjee
et al. 2012;Carvalhoetal.2013)a
ndBacillus spp. (Le et al. 2005) have also been reported to
be present in farmed shrimp, which makes antibiotic resistance in shrimp aquaculture a
legitimate issue to be resolved. The countries at a greater risk of climate change will likely
face a higher incidence of antibiotic resistance in the future, thus extending its threat not just to
aquatic life but also to human health (Reverter et al. 2020). Therefore, it is vital to develop
sustainable alternatives to antibiotics in shrimp aquaculture as a disease management strategy.
An overview of the pros and cons of the alternative strategies discussed throughout the review
is represented in Table 1.
1593Aquaculture International (2021) 29:1591–1620
Nanomaterials and their versatile applications in shrimp aquaculture
Nanoparticles are particles ranging from 1 to 100 nm with unique properties attributed to their
size (Bowman 2017). Metallic salts are reduced to form nanoparticles with thehelp of reducing
agents (Van Hyning et al. 2001), whereas polymeric nanoparticle synthesis is carried out by
polymerizing monomers by various methods (Nasir et al. 2015). Nanotechnology is applied in
the field of biology for the development of drug delivery systems, bio-imaging, and gene
delivery. It offers a variety of applications in aquaculture as carriers in vaccine delivery,
diagnostic tools, antimicrobial agents, and anti-biofilm agents (Fig. 1).
Vaccine delivery
Vaccination is practiced in aquaculture as a prophylactic measure to improve host immunity
against infections. Several researchers have focused on developing oral DNA vaccines for
shrimp using carriers like PLGA (poly-lactide-coglycolide acid) and chitosan for viral and
bacterial diseases. The carriers are now widely used because they are biodegradable, water-
Table 1 A brief summary of advantages and disadvantages of different strategies employed as an alternative to
antibiotic therapy
Antimicrobial
agent
Pros Cons
Nanomaterials Versatile applications in infection therapy as
antimicrobial agents, antibiofilm agent (Moges
et al. 2020) and vaccine components
(Rajeshkumar et al. 2009).
Environmental toxicities associated
with the use of nanoparticles (Zoroddu
et al. 2014)
Broad spectrum antimicrobial activity against
pathogens (Camacho-Jiménez et al. 2020).
Phages Effective tool for the delivery of genes and
antigens (Solís-Lucero et al. 2016;Dyetal.
2018).
Stabilization of phage formulation for
therapy is cumbersome task to
accomplish (Ssekatawa et al. 2021).
Availability of multiple routes in administration
of phages (Nakai et al. 1999; Nakai and Park
2002).
Difficulty in isolating phages that do
not harbor genes conferring antibiotic
resistance and virulence (Ssekatawa
et al. 2021).
Biofilm-based
vaccines
Improved immune response can be achieved
without the use of adjuvants (Vinay et al.
2016).
Possible immune tolerance due to high
or low dosing (Vinay et al. 2016).
Phytobiotics Multiple health benefits including improved
growth and relief from oxidation stress
(Elumalai et al. 2020).
Possibility in the development of
antibiotic resistance when single
active ingredient is used (Gupta and
Birdi 2017).
Short duration outcomes were found to be as
effective as long-term ones (Reverter et al.
2021)
Algal extracts Enhances growth and performance of shrimp
along with antimicrobial activity (Lee et al.
2020).
Disparities in bioactive molecules
obtained depending on the extraction
method employed (Klongklaew et al.
2020)
Probiotics,
Prebiotics
and
Synbiotics
In addition to immunomodulation and
antimicrobial activity, they can sustain intestinal
health (Amenyogbe et al. 2020).
Complications related to the
development of species-specific
probiotics, prebiotics and synbiotics
(Amenyogbe et al. 2020).
1594 Aquaculture International (2021) 29:1591–1620
soluble, and non-toxic (Chalamcherla 2015). Chitosan/DNA construct (pVp28) nanoparticles
administered orally in P. monodon showed improved immunity and enabled protection against
WSSV (Rajeshkumar et al. 2009). Chitosan nanoparticles loaded with the outer membrane
protein K (ompK) gene of V. parahemolyticus stimulated an immune response against the
pathogen in Acanthopagrus schlegelii (Li et al. 2013); however, its efficacy in shrimp is
unknown. Liposome-based vaccines have also been experimented in shrimp aquaculture as
they are considered safe because of their compositional similarity to that of cell membranes.
Liposome-based nanoparticles have an additional advantage in protecting the antigenic com-
ponent from hydrolytic enzymes and pH changes, ensuring effective antigen delivery in the
host. Liposome-based recombinant VP28 vaccine when administered orally for 7 days against
WSSV showed 78.9% survival rates in Marsupenaeus japonicus (Mavichak et al. 2010).
Experimental studies regarding the development of spike protein-based nanoparticles,
dendrimers, and carbon nanotubes have not progressed much in aquaculture compared to
human medicine. The vaccination strategies presently followed in aquaculture can be im-
proved considerably with the help of these nanoparticles as they serve as a means of mass
vaccinations without the burden of injections.
Diagnostic tools
Nanoparticles have become an integral part of diagnostic methods employed for the detection
of human and animal pathogens. Gold nanoparticles have gained a lot of attention in
diagnosing shrimp diseases of viral, bacterial, and protozoal origin. Notomi et al. (2000)
described loop-mediated isothermal amplification in which a target DNA is amplified in
isothermal conditions efficiently even in the presence of undesirable DNA fragments. This
Fig. 1 Applications of nanomaterials in shrimp aquaculture. Multiple applications of nanomaterials such as
disease diagnosis, anti-microbial agents, anti-biofilm agents, and delivery of vaccines to shrimp have been
illustrated
1595Aquaculture International (2021) 29:1591–1620
detection method requires agarose gel electrophoresis and excludes a hybridization step that
would help understand DNA structures nature.
Gold nanoparticles can be bound to alkyl thiol-terminated oligonucleotides as they are
highly stable in saline conditions allowing hybridization with a complementary strand of DNA
(Arunrut et al. 2016). Nanoparticles have surface plasmon resonance, which depends on the
distance between the particles. Thus, when nanoparticles clump together, their surface plasmon
resonance absorption band changes in the visible region accompanied by a color change from
red to purple-blue. This property is utilized for colorimetric detection of successful hybridiza-
tion visible to the naked eye (Arunrut et al. 2016). This method also saves time as PCR or gel
electrophoresis is not required. Gold nanoparticles were found to improve the sensitivity of
immune assays and allowed detection of small quantities of anti-sera. An immune dot-blot
assay for detecting WSSV in shrimp was developed by raising a secondary antibody against
the anti-sera of WSSV in hemolymph (Thiruppathiraja et al. 2011). These secondary antibod-
ies were conjugated with the enzyme alkaline phosphate, linked to gold nanoparticles. The
newly devised method had 91.6% efficiency compared to the conventional immune dot-blot
assay and detected even 1ng/mL concentration of antibodies against WSSV (Thiruppathiraja
et al. 2011).
Gold nanoparticles were used to develop the Reverse Transcription-Loop-mediated iso-
thermal amplification/visual colorogenic nano-gold hybridization probe assay to detect the
Yellowhead virus in shrimp. In this study, the gold nanoparticles were used for probing DNA
strands complementary to viral DNA (Jaroenram et al. 2012). A modified Loop-mediated
isothermal amplification method with the incorporation of gold nanoparticles against
microsporidian E. hepatopenaei could detect even 0.02 fg in the sample (Suebsing et al.
2013). Similarly, gold nanoparticles were used to improve loop-mediated isothermal amplifi-
cation in detecting shrimp pathogens, IMNV, and V. parahaemolyticus (VPAHPND)(Arunrut
et al. 2013; Arunrut et al. 2016). Exploring other nanomaterials with high-quality sensor
properties will aid the development of nano-based biosensors for the detection of infectious
diseases in aquaculture.
Antimicrobial agents
Nanoparticles have been used as antimicrobial agents in the areas of medicine, food, and
agriculture. Nanoparticles can be fed to shrimp by mixing it with the feed or applied in the
water used for rearing (Luis et al. 2019). These are the common practices for nanomaterial
application, but innovations have been introduced recently. Sarkheil et al. (2016)
immobilized silver nanoparticles (AgNPs) on silica beads in a water filter column capable
of killing luminous Vibrio sp. Persian1. Filtered seawater used for rearing the post larval
stage of P. vannamei improved not only their survival rate but also their growth
performance.
The nanoparticle size is proved to be one of the key factors that influence antimicrobial
nature. Smaller nanoparticles have better antimicrobial activity, and this property is attributed
to the large surface area to volume ratio in smaller particles (Ramamoorthy et al. 2013). Gold
nanoparticles (AuNPs) of size 18 nm exhibited immunostimulation and reduced AHPND
associated histopathological damages in shrimp without exerting any signs of toxicity upon
single oral administration (Tello-Olea et al. 2019).
Among the metal nanoparticles, AgNPs are more commonly used in shrimp aquaculture as
it has been highly studied and frequently reported due to its performance as a robust
1596 Aquaculture International (2021) 29:1591–1620
antimicrobial agent (Meneses-Márquez et al. 2019). Besides its antimicrobial activity, AgNPs
have been assessed to find any possible toxicities associated with their use in shrimp. AgNPs
administered intramuscularly to juvenile whiteleg shrimp P. vannamei, at a concentration
below 20 ng/μL showed no signs of behavioral changes or mortality after 96 h. Also, the
routine oxygen consumption rate and total hemocyte counts in shrimpwere found to be normal
after administering AgNPs, suggesting that shrimp were not under stress (Juárez-Moreno et al.
2017).
AgNPs derived from the leaf extract of Camellia sinensis after long-term treatment in
Feneropenaeus indicus infected with V. harveyi showed a 71% decrease in mortality caused
by the pathogen (Vaseeharan et al. 2010). AgNPs synthesized using coastal plant Prosopis
chilensis when fed for 30 days in P. monodon challenged with Vibrio cholerae,V. harveyi,and
V. parahaemolyticus had a higher hemocyte count and phenoloxidase activity suggesting
immunomodulatory effects (Kandasamy et al. 2013). Green AgNPs synthesized using tea
and neem leaf extract proved to treat shrimp infected with necrotizing hepatopancreatitis
bacterium (NHP-B), a rickettsial pathogen (Acedo-Valdez et al. 2017). Alvarez-Cirerol et al.
(2019) synthesized AgNPs using the plant extract of Rumex hymenosepalus and found that the
nanoparticle inhibited V. parahemolyticus and increased the survival of post-larval shrimp.
AgNPs synthesized using seagrass Cymodocea serrulate showed restoration of
hepatopancreatic function when fed to Penaeus monodon infected with V. parahaemolyticus
(Rathnakumari et al. 2018).Maldonado-Muñiz et al. (2020) used extracts of seaweed Ulva
clathrate for AgNP synthesis and found that treatments with nanoparticles showed no lethality
after feeding the shrimp for 7 days. AgNPs synthesized using Spirulina extract reduced the
virulence of V. parahemolyticus and enhanced survival of Artemia nauplii challenged with the
pathogen (Palanisamy et al. 2017). Antiviral activity of commercially available AgNP called
Argovit, against WSSV, was reported by Juárez-Moreno et al. (2017) and Romo-Quiñonez
et al. (2020).
The majority of studies have reported metallic nanoparticles, and only a few have reported
the use of polymeric nanoparticles as an antimicrobial agent in aquaculture. Chitosan nano-
particles upon dietary administration for 12 days improved immunity against WSSV in
crayfish and inhibited virus replication (Sun et al. 2016). Metallic nanoparticles are non-
biodegradable and promote biomagnification, whereas polymeric nanoparticles are less toxic
to the biological system and are environmentally benign (Moges et al. 2020). Given that
polymeric nanoparticles enable the sustained release of drugs, the application of antimicrobial
agents loaded in nanoparticles can open new horizons in shrimp disease management.
Anti-biofilm agents
Quorum sensing is a cell-to-cell communication system observed in bacteria that controls the
expression of virulent genes and biofilm formation (Nealson et al. 1970). Aquaculture
pathogens such as V. harveyi,V. parahaemolyticus, Vibrio anguillarum, and Vibrio vulnificus
are capable of quorum sensing (Defoirdt et al. 2004). Biofilm forming pathogens cause
persistent infections and are recalcitrant to antibiotic therapy (Karunasagar et al. 1996). This
calls for suitable alternatives to inhibit biofilm infections of aquaculture pathogens.
AgNPs synthesized using Gelidiella acerosa, red algae, inhibited biofilm formation,
production of extracellular polysaccharide (EPS), swimming, and swarming motility without
affecting the growth of V. vulnificus and V. parahaemolyticus (Satish et al. 2017). Copper
nanoparticles were found to retard EPS production and cell surface hydrophobicity (CSH) and
1597Aquaculture International (2021) 29:1591–1620
hence controlled the biofilm formation by V. alginolyticus, V. parahaemolyticus, and
A. hydrophila (Chari et al. 2017) (Table 2).
These studies have reported the efficacy of nanoparticles under in vitro conditions against
the shrimp pathogens. Lack of in vivo studies limits the knowledge on the virtue of
nanoparticle-based biofilm treatment in aquatic animals.
Despite their attractive properties and vast applications in aquaculture, several reports
support the toxicity associated with the use of metallic nanoparticles in the environment
(Zoroddu et al. 2014). Studies conducted so far have analyzed the advantage of nanoparticles
with short-term exposure. Whether or not these nanoparticles have a detrimental effect on
shrimp or develop antimicrobial resistance to nanoparticles after a long time of exposure needs
to be addressed. Also, safety assessment of nanoparticle treated shrimp for human consump-
tion have to be studied before use. Green and biological synthesis of nanomaterials is
considered safe and environmentally benign (Singh et al. 2018). More application studies in
aquaculture utilizing green and biologically synthesized nanoparticles will allow their success-
ful implementation in the future.
Biofilms in shrimp aquaculture: the positive side
As mentioned earlier, biofilms of pathogens can cause persistent infections. Bacterial
biofilms as a source of immunostimulants for fishes have emerged to be a successful
strategy since they can be used directly without encapsulation or adjuvants for delivery
(Vinay et al. 2016). The expression of proteins in biofilm cells and planktonic cells are
dissimilar; therefore, cell vaccines with new immunogens can be developed using biofilms
(Mamun et al. 2019). In addition, oral immunostimulation is a more fiscal and rational
strategy for aquaculture practices (Sharma et al. 2010). Biofilm-based immunostimulants
are prepared by growing biofilms of pathogens on chitin flakes, which are inactivated either
by heat or formalin and are then mixed with feed using a binder (Mamun et al. 2019;
Sharma et al. 2010).
The supplementation of inactivated V. alginolyticus biofilms on chitin flakes in the feed
showed antimicrobial effects, enhanced phenoloxidase activity, and rise in total haemocyte
count, thus stimulating immunity of shrimp (Sharma et al. 2010). P. monodon fed with biofilm
cells of V. alginolyticus at a dose of 109CFU/g of shrimp for 14 days displayed resistance to
V. alginolyticus and WSSV infections. Similarly, inactivated biofilms of V. harveyi supple-
mented in shrimp feed for immunostimulation of P. vannamei showed enhanced lysozyme
activity, increased production of penaeidin, crustin and antimicrobial peptides (Vinay et al.
2019). Heat-inactivated cells of A. hydrophila were developed as novel antigens for oral
vaccination in fishes (Mamun et al. 2019). This can be extended in whiteleg shrimp for
immunostimulation since A. hydrophila is reported as an emerging bacterial pathogen (Zhou
et al. 2019).
Beneficial role of bacteriophages in shrimp aquaculture
Bacteriophages are viruses that can integrate into the bacterial DNA and induce the lysis of the
bacterialcells. The tail and tail fibers of bacteriophages help in the adherence of the virus to the
host receptors present on the outer surface of bacteria, following which the viral particles inject
1598 Aquaculture International (2021) 29:1591–1620
Table 2 Antibacterial, antiviral, and anti-biofilm activity of nanoparticles against shrimp pathogens
Pathogen Nanoparticle Activity Mode of synthesis Concentration Size and shape of the nanoparticle References
V. parahaemolyticus AuNP Antibacterial
activity
Chemical (Turkevich method) 2 μg/g Ovoid shape, 18.57 ± 4.37 nm Tello-Olea et al.
(2019)
V. parahaemolyticus AgNP Biological (Spirulina extract) 5 μg/mL spherical shape,
2- 18nm.
Palanisamy et al.
(2017)
V. harveyi AgNP Commercial (Nanocid) 391 μg/mL 16.62 nm Bahabadi et al. (2017)
V. parahaemolyticus AgNP Biological (U. clathrate
extract)
3.2 μg/mL spherical shape, 5 to 20 nm. Maldonado-Muñiz
et al. (2020)
V. parahaemolyticus AgNP Biological (R. hymenosepalus
extract)
25 μg/mL quasi-spherical geometry, size 2 and
10nm.
Alvarez-Cirerol et al.
(2019)
Vibrio harveyi AgNP Biological (C. sinensis extract) 10 μg/mL - Vaseeharan et al.
(2010)
V. cholerae, V. harveyi and V.
parahaemolyticus
AgNP Biological (P. chilensis
extract)
- spherical shape, 5 to 25 nm Kandasamy et al.
(2013)
Necrotizing hepatopancreatitis
bacterium (NHP-B)
AgNP Biological (Azadirachta indica
aextract)
35 μg polyhedral, semi-hemispherical and
flattened shapes,
5to45nm.
Acedo-Valdez et al.
(2017)
WSSV AgNP Antiviral
activity
Commercial (Argovit) 5 and 20
ng/mL
spheroid shape ,35 ± 15 nm diameter Juárez-Moreno et al.
(2017)
WSSV AgNP Commercial (Argovit) 1,000 μg/g - Romo-Quiñonez et al.
(2020)
WSSV Chitosan NP Physicochemical (Ultrafine
milling method)
10 mg/g spherical shape, size ranging from 20
to 1000 nm
Sun et al. (2016)
V. vulnificus and V. parahaemolyticus AgNP Anti-biofilm
activity
Biological ( G. acerosa
extract)
100 μg/mL spherical shape, size ranging from 20
to 50 nm
Satish et al. (2017)
V. alginolyticus,V. parahaemolyticus
and A. hydrophila
CuNP Chemical (One-pot synthesis
method)
100 ng/mL Spherical shape with average size of
55nm
Chari et al. (2017)
1599Aquaculture International (2021) 29:1591–1620
their genetic material into the bacterial host (penetration) after which the phage undertakes the
host machinery for its replication (Weinbauer 2004). Once the viral components are synthe-
sized, they are assembled to form mature phage particles that are eventually released out of the
cell by lysis followed by a repetition of the cycle (Weinbauer 2004). The principal advantage
of using phages for treatment is their abundance, ease of multiplication by regulating bacterial
growth, environment-friendly characteristics, and host-specificity as they will not interfere
with gut microbiota and therefore show minimal side effects when compared to antibiotic
therapy (Oliveira et al. 2012). Phages have been used to control bacterial diseases, and some
are genetically engineered for antiviral therapies.
Phages against bacterial infections in shrimp
Phage therapy is carried out by administering the phages through injection, dietary adminis-
tration, and incorporation in rearing systems (Nakai et al. 1999; Nakai and Park 2002). But
dietary administration is desirable as it helps treat large populations and prevents infections in
the intestine (Nakai 2010).
Nikapitiya et al. (2020) reported that live Artemia nauplii supplemented with Edwardsiella
tarda phage (ETP-1) when fed to zebrafish did not impart any adverse immune reaction
suggesting that this method of phage delivery can be inculcated for the treatment of bacterial
diseases in aquaculture. Phage therapy was found to be successful in treatment at all stages of
infection caused by V. parahaemolyticus in P. vannamei larvae (Lomelí-Ortega and Martínez-
Díaz 2014). In vitro studies showed that the phage pVp-1 was capable of lysing acute
hepatopancreatic necrosis disease (AHPND) causing strains of V. parahaemolyticus (Jun
et al. 2016) and later was found to have prophylactic as well as therapeutic potential in shrimp
(Jun et al. 2018). Phage cocktails, which are a combination of phages, have been found to act
synergistically than using single phages. Mateus et al. (2014) studied three phages VP-1, VP-2,
and VP-3 isolated from marine water against V. parahaemolyticus and found their combination
to be more effective. Makarov et al. (2019) combined T2A2 and VH5e bacteriophages for
effective lysing of AHPND causing V. parahaemolyticus strains. Ma et al. (2019) developed a
phage cocktail consisting of five novel phages belonging to the family of Siphoviridae, which
inhibited the growth of Vibrio sp. Va-F3 and survival rate of infected shrimp. Kalatzis et al.
(2016) administered a suspension of phages φSt2 and φGrn1 to brine shrimp Artemia salina
infected with V. alginolyticus strain V1 and observed that the load of bacteria was reduced by
93% within 4 hrs. Phages have also been documented for anti-biofilm activities against shrimp
pathogens. Prada-Peñaranda et al. (2018) used a phage preparation FBL1, targeting biofilmsof
Bacillus licheniformis strain 52 known to cause high mortalities in juvenile and adult
P. vannamei. The phage preparation reduced the biofilms of B. licheniformis to 44.77%
(Prada-Peñaranda et al. 2018).
Apart from thedirect use of phagecocktails for bacterial lysis, endolysin genes from phages
have been cloned and expressed for therapeutical application in aquaculture. The phage-based
endolysin (Vplys60) expressed in yeast Pichia pastoris showed in vitro antibacterial activity
against V. parahaemolyticus at 75 μg/mL and reduced bacterial load in Artemia franciscana
(Srinivasan et al. 2020). Thammatinna et al. (2020) identified a vibrio phage named Seahorse,
interfering with the protein machinery of AHPND causing V. parahaemolyticus, indicating the
presence of an antimicrobial compound encoded by the phage. These studies point out
different possibilities of using phages in shrimp aquaculture in controlling bacterial diseases
(Table 3).
1600 Aquaculture International (2021) 29:1591–1620
Table 3 Various applications of bacteriophages in shrimp aquaculture
Name of the phage/phage product In vivo host Titre of phage
used/phage prod-
uct
Targeted pathogen Key findings References
ETP-1 Zebrafish 1011 PFU/mL - No phages persisted in spleen and liver after 7 days of feeding
with artemia enriched phages.
Nikapitiya
et al.
(2020)
VP-1, VP-2, and VP-3 - 107PFU mL V. parahaemolyticus Phages were viable for upto 7 months Mateus
et al.
(2014)
Bacterial inhibition upto 4.2 log within 6 h incubation
pVp-1 P. vannamei 1.5 × 108
PFU/shrimp
V. parahaemolyticus Combination of prophylactic and therapeutic administration of
phage by oral route caused highest reduction in mortality
Jun et al.
(2016)
T2A2 and VH5e A. franciscana MOI = 1 V. parahaemolyticus
CVP2
Phage cocktail was active against bacterial suspension of 6 × 106
and 6 × 107CFU/ml tested in vivo
Makarov
et al.
(2019)
Phage cocktail of VspDsh-1, ValLY-3,
ValSw-1, VpaJT-1, and VspSw-1
P. vannamei 2×10
7PFU/ml Vibrio sp. Va-F3 Survival rate of shrimp was 91.4% after 7 days of treatment Ma et al.
(2019)Phage cocktail exhibited inhibitory activity against
phage-resistant Va-F3 variants
φSt2 and φGrn1 A. salina MOI = 100 V. alginolyticus Vibrio load in Artemia was reduced to 5.3 x 103±3.1 x 103
CFU/mL after 4 h of phage treatment
Kalatzis
et al.
(2016)
Peptide 2E6 Freshwater
crayfish
50 μL WSSV Mortality was reduced to 33.38 % with an increase in median
lethal time (LT50) for 20 days
Yi et al.
(2003)
1601Aquaculture International (2021) 29:1591–1620
The resistance of bacteria to phages occurs when the virus cannot adhere to the cell
membrane due to loss of receptors (Oliveira et al. 2012). In addition to this, restriction
enzymes and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) sys-
tems in bacteria also render resistance to phage infection (Hyman and Abedon 2010). A
study conducted by Laanto et al. (2020) found that myophage FCV-1-resistant clones of
Flavobacterium columnare emerged within 1 day of co-culture. But after a week, phage
isolate capable of infecting more than half of the previous phage-resistant clones were
identified (Laanto et al. 2020). Hence, trained phages that have naturally co-evolved to
infect phage resistant clones can be used while preparing phage suspension for treatment
purposes.
Generally, in phage therapy, only lytic phages are preferred as temperate phages can
lysogenise bacterial cells and transfer virulent genes/ antibiotic-resistant genes via horizontal
gene transfer (Oliveira et al. 2015). But some reports have confirmed the presence of
horizontal gene transfer in lytic phages via transformation and transduction. Two natural lytic
phages were found to transmit transformable plasmid DNA bearing antibiotic-resistant genes
from Escherichia coli to Bacillus sp. (Keen et al. 2017), and E. coli phages from urban
wastewater was found to transduce β-Lactam resistance genes (Gunathilaka et al. 2017).
Besides this, the existence of virulent mutants of temperate phages in nature should not be
ignored as they can revert to lysogeny, complicating the treatment (Krylov 2001). These
findings indicate the possible hazards of using phages for the treatment of antibiotic-resistant
infections.
Phage display technology to combat viral diseases in shrimp aquaculture
WSSV is a major concern for shrimp aquaculture globally and has caused an estimated loss of
seven billion dollars in shrimp aquaculture industries located in Asia and America in the 1990s
(Arulmoorthy et al. 2020). Yi et al. (2003) constructed a 10-mer phage display peptide library
and found that the peptide 2E6, with VAVNNSY critical motif, reduced pathological signs of
WSSV infection in freshwater crayfish. Phage display technology for detecting viral pathogens
is cost-effective because it does not demand any antigen purification steps, and neutralizing
scFv antibody synthesis is carried out in bacterial hosts (Yuan et al. 2006). Yuan et al. (2006)
reported a neutralizing antibody from the anti-WSSV single-chain fragment variable region
(scFv) antibody phage display library, which could be a potential tool for WSSV detection and
treatment. Phage display technology has also been implemented in vaccination technique for
the delivery of antigens. Solís-Lucero et al. (2016) constructed a recombinant phage that
expressed VP28 protein for vaccinating shrimp against WSSV infection. Phage display
technology can be extended for other infectious viral diseases in shrimpto identify neutralizing
antibodies and potential antigens for prophylaxis and disease diagnosis.
Phytobiotics for shrimp disease management
Phytobiotics are plant extracts that generally contain bioactive compounds like phenolics,
tannins, flavonoids, and essential oils with antimicrobial and immunomodulating activity
(Chakraborty and Hancz 2011). Phytobiotics have less tendency to induce resistance in
pathogens, which can be attributed to various molecules present in them and are cost-
effective and eco-friendly than synthetic compounds like antibiotics (Logambal et al. 2000;
1602 Aquaculture International (2021) 29:1591–1620
Blumenthal 2000; Olusola et al. 2013). The oral route of administration is being widely
practiced since it is found to be effective and easy (Yoshida et al. 1995).
Phytobiotics as an immunomodulating agent
Several pieces of research have reported the immunomodulating effects of plant extracts
in shrimp. Leaf extracts of mangrove plant Xylocarpus granatum improved the survival
rate of shrimp post V. harveyi infection by increasing the population of haemocytes such
as hyaline cells, semi-granular, and granular in shrimp (Saptiani et al. 2020a). The
powdered form of bulbs of the medicinal plant Eleutherine bulbosa administered in
shrimp feed improved immune genes expression and restricted V. parahaemolyticus
infection (Munaeni et al. 2020). Lee et al. (2020) observed that injection of Theobroma
cacao pod husks in shrimp resulted in an enhanced expression of immune genes like toll-
like receptors (TLR- 1), signal transducer and activator of transcription (STAT), and
crustin in shrimp, concluding its immunomodulating effect on the innate immune system
of shrimp.
Individual components from plant extracts have also been employed as immunomodulating
agents for shrimp. α-Phellandrene, a compound present in essential oils of herbs upregulated
mRNA levels of immune genes lipopolysaccharide- and β-1,3-glucan-binding protein,
prophenoloxidase, and peroxinectin after V. alginolyticus challenge (Wu et al. 2019). These
studies collectively demonstrate that plant extracts could be used as immune stimulators in
shrimp farming.
Phytobiotics as antimicrobial agents
Phytobiotics have been extensively studied in shrimp aquaculture as they harbor compounds
that can interfere with the bacterial cell wall and viral mRNA synthesis (Jana et al. 2018). The
ethanolic extract of the plant Cynodon dactylon contained antiviral compounds like epicate-
chin, p-coumaric acid, catechin, vanillic acid, syringic acid, and quercetin, which rendered
protection against WSSV in shrimp upon intramuscular injection of the extract (Howlader
et al. 2020). Olea europaea leaf extracts, when orally administered to shrimp juveniles,
improved the survival rate by 65% towards WSSV infection (Gholamhosseini et al. 2020).
Ascorbic acid monophosphate and Phytocee, a commercial phytogenic feed comprising of
the extracts of Emblica officinalis, Ocimum sanctum, and Withania somnifera, conjointly
increased the survival rate of shrimp challenged with WSSV (Selvam et al. 2020). Enrichment
of chitosan and mangrove flour as windu shrimp feed was also found to reduce the mortality
associated with WSSV in shrimp (Manik et al. 2020). Cahyadi et al. (2020)fortifiedA. salina
using the fruit extract of Sonneratia alba and orally administered the bio-enriched Artemia to
inhibit V. harveyi infection in shrimp.
Apart from antibacterial and anti-viral activity, certain phytochemicals have shown prom-
ising anti-fungal and anti-parasitic activities against shrimp pathogens. S. alba leaf extract was
capable of preventing Saprolegnia sp. and V. harveyi infection in tiger shrimp when admin-
istered in the rearing system (Saptiani et al. 2020b). Plant products like ginger paste (Zingiber
officinale), lemon juice (Citrus limon), garlic homogenate (Allium sativum), jaggery powder
(Borassus flabellifer), black gram flour (Vigna mungo) is mixed with shrimp feed by shrimp
farmers of South India to curb E. hepatopenaei infections effectively (Palanikumar et al. 2020)
(Table 4).
1603Aquaculture International (2021) 29:1591–1620
Table 4 Applications of phytobiotics in shrimp aquaculture
Phytobiotic Purpose Pathogen In vivo host Dosage and period of administration References
E. bulbosa bulb powder Immunostimulants V. parahaemolyticus P. vannamei 12.5 g/Kg of shrimp for 30 days Munaeni et al.
(2020)
Hot-water extract T. cacao pod
husk extract
V. alginolyticus P. vannamei 40 μg/ shrimp injected once Lee et al. (2020)
Distilled water extract of
X.granatum leaf extract
V. harveyi P. monodon 1.250 ppm Saptiani et al.
(2020a)
α-Phellandrene V. alginolyticus P. vannamei 8 and 12 μg/Kg of shrimp for 72 h Wu et al. (2019)
Ethanolic extract of C. dactylon Antiviral WSSV P. vannamei 150 mg/Kg body weight injected once Howlader et al.
(2020)
Methanolic leaf extract of
O. europaea
WSSV P. vannamei 200 mg/Kg of the shrimp biomass for 7 days Gholamhosseini
et al. (2020)
Ascorbic acid monophosphate and
Phytocee
WSSV P. vannamei 500 g/ton feed of ascorbic acid monophosphate and 1000 g/ton
feed of Phytoceefed for 42 days
Selvam et al.
(2020)
Chitosan and mangrove flour WSSV P. monodon 300 g of Chitosan and mangrove flour per 1 Kg of commercial
feed
Manik et al. (2020)
Saline water extract of S. alba Anti-fungal Saprolegnia sp. P. monodon 1250 mg/L added once in the rearing system Saptiani et al.
(2020b)Antibacterial V. harveyi
Ethanolic fruit extract of S. alba
enriched in A. salina
V. harveyi P. monodon 20 ppm of extract for 10 days Cahyadi et al.
(2020)
Z. officinale paste Anti-parasitic E. hepatopenaei P. vannamei 20 g /Kg of feed Palanikumar et al.
(2020)
C. limon juice 50 mL/Kg of feed
A. sativum homogenate 20 g/ Kg of feed
B. flabellifer powder 30 ml of jaggery syrup (1 Kg/L) per 1 Kg of feed
V. mungo flour 50g/Kgoffeed
1604 Aquaculture International (2021) 29:1591–1620
Most of these studies have focused on assessing the antimicrobial activity of the plant
extract as a whole, rather than identifying the key molecule possessing antimicrobial property.
It is necessary to identify the active components from the extract to calculate the dosage and
toxicity level and understand their mechanism of action before large scale applications.
Therapeutic applications of marine algal extracts for shrimp disease
management
Marine algae are known to produce bioactive compounds, and compared to antibiotics, these
compounds are safe to the environment and have good antimicrobial properties, due to which
they can be used in shrimp aquaculture (Dashtiannasab et al. 2016). Algal extracts can be
administered to shrimp by injection, immersion, and feed supplement (Huang et al. 2006;Yeh
et al. 2006). Hot-water extract of the seaweed Sargassum duplicatum at a concentration below
10 μg/g, when injected into P. vannamei, enhanced immune response against
V. parahemolyticus infection (Yeh et al. 2006). Selvin et al. (2011) formulated a medicated
diet using the secondary metabolites of marine algae, Ulva fasciata which was highly effective
in controlling shrimp bacterial infections at a dose of 1 g/kg of shrimp. Apart from bacterial
infections, seaweed extracts have also been studied against viral infections. The extract of the
algae, Sargassum hemiphyllum var. chinense when administered to white shrimp exhibited
improved resistance to WSSV infections (Huynh et al. 2011).
Metabolites derived from marine algae are incorporated in shrimp feeds to improve the
resistance of shrimp to infections. The polysaccharide fucoidan from the algae, Sargassum
wightii when supplemented at 0.3% in the feed of P. monodon for 45 days, showed a decrease
in mortality associated with WSSV infection (Immanuel et al. 2012). An antiviral compound,
2-(2-hydroxyphenoxy)-1-phenylethanol from Enteromorpha flexuosa at 400 mg/kg when fed
to F. indicus provided resistance to WSSV infection due to augmented immunity (Velmurugan
et al. 2015). Dietary administration of polysaccharide extract of the seaweed Sargassum
fusiforme in juvenile shrimp, Fenneropenaeus chinensis enhanced resistance against vibriosis
and improved its immunity (Huang et al. 2006). Dietary administration of the protein extract of
red seaweed Gracilaria fisheri at 100 μg/ mL in whiteleg shrimp exhibited better survival and
had normal histological features of hepatopancreas when challenged with V. parahaemolyticus
(Boonsri et al. 2017).
Marine algae are an excellent source of quorum quenching compounds that can reduce the
biofilm formation of bacterial pathogens of shrimp. Ethanolic extract and furanone from
G. fisheri inhibited biofilms of V. parahaemolyticus and V. harveyi, respectively, at sub-
MIC concentrations and reduced mortality of shrimp that received these compounds through
diet (Karnjana et al. 2019).
The cost involved in extraction methods to obtain algal compounds is high (Ibañez et al.
2012); therefore, new techniques should be developed to perform the extraction in a cost
convenient manner. A study conducted by Manilal et al. (2009) showed that the antimi-
crobial property of extract of Asparagopsis taxiformis varied seasonally and highest
activity against shrimp pathogens, was recorded in the months of December and January.
Thus, the compositional analysis of algal extracts with respect to seasonal variations has to
be considered while developing antimicrobial compounds for aquaculture. Further analysis
and characterization of bioactive compounds from the algal source are required to develop
various formulations.
1605Aquaculture International (2021) 29:1591–1620
Microbial interventions in shrimp aquaculture
Probiotics are mono or mixed culture of live microorganisms used to improve the properties
of the indigenous microflora (Havenaar and Huis IntVeld1992), boost shrimp innate
immunity and work antagonistically towards the pathogens by secreting antimicrobial
compounds (Hai and Fotedar 2010). The probiotic microorganisms provide digestive
enzymes to the shrimp and compete for nutrients in the environment, thus keeping the
pathogen population in control (Irianto and Austin 2002). Probiotics can be administered
by immersing shrimp in probiotic suspension or orally by mixing them with feed (Itami
et al. 1998; Sakai 1999). Oral administration is much more effective in treatment because it
targets shrimp of all stages (Sakai 1999), while the immersion method is effective in the
juvenile stage (Itami et al. 1998).
Prebiotics are dietary components that support the sustenance of beneficial microorganisms
in the gut (Hai and Fotedar 2009). Prebiotics are mostly indigestible carbohydrates, which
could be a monosaccharide, oligosaccharide, or polysaccharide (Akhter et al. 2015). Prebiotic
act as immunostimulants as they can interact with pattern recognition receptors (PRRs) present
on macrophages (Bron et al. 2012).
Synbiotics are a combination of prebiotics and probiotics which can be provided as dietary
components to promote the health of individual organisms, help in the colonization and
maintenance of dietary microbial supplements in the gut, and promote the growth of beneficial
microbiota to improve the host health (Cerezuela et al. 2011, Gibson and Roberfroid 1995).
The following session discusses how probiotics, prebiotics, and synbiotics can benefit shrimp
aquaculture.
Probiotics, prebiotics, and synbiotics to combat infectious agents
Probiotic bacteria can activate the immune system of shrimp to prevent infections. A probiotic
bacteria M146 administered orally reduced shrimp mortality and showed an
immunostimulatory effect in shrimp by downregulating the genes of IMD and Toll signaling
pathways. On the contrary, W1B, another probiont did not display any immunostimulatory
effect but acted as an effective antimicrobial and quorum quenching agent against V. harveyi
(Yu et al. 2020). Khademzade et al. (2020) found that the addition of probiotic bacteria
Bacillus cereus in rearing water showed better immunostimulatory effects in shrimp reared in
the earthen pond with an enhanced lysozyme activity and increased total haemocyte count.
Hence, probiotics act similar to vaccines by triggering the immune system, due to which they
can be utilized as prophylactic agents.
Probiotic bacteria can compete for space and nutrition, thus excluding these pathogens from
the shrimp intestine (Dash et al., 2017). Feeding shrimp with B. cereus caused extensive
colonization of the probiont in shrimp and significantly reduced the population of
V. alginolyticus and V. parahaemolyticus in the intestine (Vidal et al. 2018). The shrimp fed
with a freeze-dried probiotic consortium including Bacillus subtilis BUU 005, Bacillus
polymyxa BUU 003, Bacillus megaterium BUU 002, B. licheniformis BUU004,andBacillus
thuringiensis BUU001 showed a significant reduction in the colonization of
V. parahaemolyticus and V. cholerae in the gut of juvenile shrimp (Nimrat et al. 2019).
B. subtilis strain IPA-S.51 and Shewanella algae strain IPA-S.252 provided in shrimp feed
reduced the load of Vibrio sp. in the hepatopancreas of shrimp (Interaminense et al. 2018).
Dietary administration of Lactobacillus sakei strain FB011 displayed immunomodulatory
1606 Aquaculture International (2021) 29:1591–1620
effect and anti-Vibrio effect in shrimp (Le and Yang 2018). Probiotic supplementation of
Bacillus PC465 in feed, boosted the resistance of shrimp to WSSV infection (Chai et al. 2016).
The intestine of healthy shrimp is a natural reservoir of symbiotic bacteria that can be used
for isolating probionts. Pseudoalteromonas sp. CDM8 and CDA22 isolated from the hindgut
of healthy shrimp were potential probiotic candidates for controlling AHPND (Wang et al.
2018). B. subtilis AHAHBS001 isolated from healthy shrimp of coastal areas displayed
significant resistance to AHPND strains of V. parahaemolyticus upon addition of the probionts
in the feed (Kewcharoen and Srisapoome 2019).
Probiotics can modulate the gut microbiota for providing resistance to microbial infections
in shrimp. Probiotic bacteria Streptomyces sp. RL8 enriched feed had a protective effect on
P. vannamei upon challenge with V. parahaemolyticus. Statistical Analysis of Metagenomic
Profiling (STAMP) revealed that the probiont stimulated antimicrobial producing
Bacteriovorax population of shrimp gut, which provided resistance to infection (Mazón-
Suástegui et al. 2019).
Prebiotic supplements can alter the gut microbiome composition by favouring the growth of
beneficial microbes (Gibson and Roberfroid 1995). Li et al. (2007) administered short-chain
fructooligosaccharides in shrimp feed for 6 weeks in shrimp and found that the prebiotic
supplementation significantly improved total haemocyte count, haemocyte respiratory burst
and altered the microbiome of the gastrointestinal tract. Mannooligosaccharides obtained from
copra meal showed immunostimulatory effects in shrimp by increasing the expression of anti-
lipopolysaccharide factor, penaedin, crustin, peritrophin, and lysozyme, which improved the
survival rate of shrimp upon exposure with V. harveyi (Rungrassamee et al. 2014). Dietary
administration of inulin and mannan oligosaccharide together in shrimp also has been proven
to upregulate immune-related genes like STAT, antilipopolysaccharide factor, crustin,
prophenoloxidase. P. vannamei challenged with V. alginolyticus and WSSV showed enhanced
resistance under this dietary scheme concluding their strong immunomodulatory action (Li
et al. 2018). Bioencapsulation prebiotics using Artemia can enhance colonization of probionts
in the shrimp, and this can be achieved by incubating the nauplii in a mixed solution consisting
of prebiotic and docosahexaenoic acid (Hoseinifar et al. 2015).
Synbiotics have been extensively studied in the field of human and veterinary medicine as
an alternative to fight infectious diseases (Cheng et al. 2014). Several studies have been
conducted to analyze the effects of synbiotics in shrimp aquaculture in controlling infectious
diseases. Huynh et al. (2018a) found that shrimp fed with a synbiotic diet consisting of
Lactobacillus plantarum and galactooligosaccharide showed enhanced immune resistance to
V. alginolyticus infection associated with increased levels of valine, inosine monophosphate,
and betaine in hepatopancreas. Later, it was proven that this diet resulted in a reduced
population of V. harveyi and Photobacterium damselae and enhanced the colonization of
L. plantarum in the intestine (Huynh et al. 2018b). Oral administration of a synbiotic
comprising Bacillus sp. D2.2 and sweet potato extract was found to lower the infection level
of V. harveyi in shrimp (Harpeni et al. 2017). Oktaviana et al. (2014) formulated a synbiotic
diet containing prebiotic oligosaccharides extracted from sweet potato and probiont
V. alginolitycus SKT-bRcapable of preventing co-infection of Infectious Myonecrosis Virus
(IMNV) and V. harveyi in shrimp.
Synbiotic preparation in dry forms are preferable than fresh preparations as they provide
longer viability of the probiont, and this can be accomplished by encapsulation of synbiotics
(Ross et al. 2005). Artemia encapsulated synbiotics containing Pseudoalteromonas piscicida
1Ub, and mannan-oligosaccharide exhibited superior immune response and resistance to
1607Aquaculture International (2021) 29:1591–1620
V. harveyi in shrimp, compared to the diet consisting bio encapsulated probiotic or prebiotic
(Hamsah et al. 2019). A micro-encapsulated synbiotic diet consisting of Bacillus sp. NP RfR
and oligosaccharide of sweet potato was found to render resistance to V. harveyi infection
(Munaeni et al. 2014). Similarly, a micro-encapsulated combination ofBacillus sp. NP RfRand
mannan oligosaccharide augmented immune response to WSSV infection (Febrianti and
Yuhana 2016). These results imply that synbiotics based diet can be employed to control
infectious in shrimp farms and hatcheries (Table 4).
Prolonged use of probiotics has been linked to cause immunosuppression (Sakai 1999), but
integrative use of probiotics with pond bottom soil improvement has proven to reduce the
incidence of Vibrio sp. in rearing systems, increase the survival of shrimp and maintain water
quality in an extensive P. monodon culture system (Pantjara and Kristanto 2020). Probionts
isolated from the terrestrial ecosystem may not give expected results in aquatic animals;
therefore, probiotic strains can be isolated from a marine ecosystem. The challenge in
exploring marine probionts is the difficulty to culture these organisms under in vitro conditions
(Ninawe and Selvin 2009). The studies reviewed here have disclosed the ability of probiotic
bacteria to control only bacterial and viral infections in shrimp. The effect of probiotic bacteria
Lactobacillus plantarum FNCC 226 in controlling fungal infection of S. parasitica in catfish
was reported by Nurhajati et al. (2012) and the effect of this probiotic bacteria can be assessed
in shrimp larvae since they are also susceptible to this fungal infection.
Role of probiotics and synbiotics in water quality improvement
The environment in which shrimp reside is also favourable to pathogenic microorganisms,
hence the chances of acquiring diseases are high and improved immunity is necessary for
survival (Decamp et al. 2008). Probiotic bacteria can be used to eliminate potential pathogens
from rearing systems and reduce the incidence of infection in shrimp farms. Shrimp fed with
probiotic strains B. licheniformis strain LS-1 and Bacillus flexus strain LD-1 showed stimu-
lated immunity and resistance to infections. In addition to this, the population of Vibrio sp. and
the amount of nitrogenous compounds were significantly lower in the rearing water systems
upon probiotic supplementation (Cai et al. 2019). Although the intestinal microbiota acts as a
major source of probiotics, beneficial bacterial strains with probiotic potential can be isolated
from other ecosystems as well. Probiotic strains L. plantarum (JK-8) and Lactobacillus
hilgardii (JK-11), isolated from shrimp ponds, improved the quality of water in shrimp rearing
ponds, and their cell-free supernatants exhibited significant antimicrobial properties against
shrimp pathogens V. parahemolyticus, V. harveyi,andE. tarda (Ma et al. 2009).These
bacteria were also capable of removing toxic wastes such as ammonia, nitrite, and nitrate
from the shrimp rearing system, highlighting their possible use in water treatment for aqua-
culture. Purple non-sulfur bacteria Rhodobacter sphaeroides strains SS15, S3W10, and
Afifella marina STW181 were also capable of reducing the levels of ammonia, nitrite, and
nitrate in rearing and increased survival of shrimp challenged with AHPND strains of
V. parahaemolyticus (Chumpol et al. 2017)(Table5).
A synbiotic diet consisting of B. subtilis and fermented rice bran reduced total Vibrio count
in the rearing water, besides improving the immune response and growth performance of
shrimp juveniles (Moustafa et al. 2020). Hence, probiotics and synbiotics can be utilized to
remove toxic nitrogenous compounds from rearing systems. Yet, the addition of probiotic
bacteria in rearing water is met with several challenges. For example, the possibility of
probiotic organisms altering the microbial consortia of natural ecosystems needs to be
1608 Aquaculture International (2021) 29:1591–1620
Table 5 Probiotics, prebiotics, and synbiotics for antimicrobial therapy in shrimp aquaculture
Probiotics Constituent Pathogen Dosage Period of
administration
References
M146 probiotic bacteria V. harveyi 1.0 × 107CFU/gofshrimp 15days Yuetal.(2020)
B. cereus -10
6CFU/mL Added once in
rearing system
Khademzade et al.
(2020)
B. cereus V. alginolyticus and
V. parahaemolyticus
1.0×108CFU/g of shrimp 14 days Vidal et al. (2018)
B. subtilis BUU 005, B. polymyxa BUU 003, B. megaterium BUU 002,
B. licheniformis BUU 004, and B. thuringiensis BUU001
V. parahaemolyticus
and V. cholerae
3.87 ± 0.606.80 ± 0.75 ×
108CFU/g of shrimp
90 days Nimrat et al. (2019)
Pseudoalteromonas CDM8 and CDA22 V. parahaemolyticus
(AHPND)
Both probionts fed at 107
CFU/kg of shrimp
21 days Wang et al. (2018)
B. subtilis AHAHBS001 V. parahaemolyticus
(AHPND)
1×10
51×10
9CFU/kg of
shrimp
5 weeks Kewcharoen and
Srisapoome (2019)
B. subtilis strain IPA-S.51 and S. algae strain IPA-S.252 Vibrio sp. 106CFU / g of shrimp 35 days Interaminense et al.
(2018)
Bacillus PC465 WSSV 107cells/g of shrimp 30 days Chai et al. (2016)
Prebiotics Short-Chain Fructooligosaccharides - 0.8% 6 weeks Hoseinifar et al.
(2015)
Copra meal derived Mannooligosaccharides V. harveyi 3 g/kg 6 weeks Rungrassamee et al.
(2014)
Inulin and mannan oligosaccharide V. alginolyticus and
WSSV
5mg/g 28days Lietal.(2018)
Synbiotics L. plantarum 7-40 and galactooligosaccharide V. alginolyticus 0.4% of prebiotic and 108
CFU/ kg of probiotic
60 days Huynh et al.
(2018a)
V. alginolitycus SKT-bRIMNV and V. harveyi 1% probiotic and 2%
prebiotic of feed weight
30 days Oktaviana et al.
(2014)
Bio-encapsulated P. piscicida 1Ub, and mannan-oligosaccharide V. harveyi 106CFU/ mL of probiont
and 12 mg/L of prebiotic
13 days Hamsah et al.
(2019)
Micro-encapsulated Bacillus sp. NP RfRand oligosaccharide of sweet
potato
V. harveyi Probiotic of 108CFU/ mL
and 2% prebiotic
40 days Munaeni et al.
(2014)
Micro-encapsulated Bacillus sp. NP RfRand mannan oligosaccharide WSSV Probiotic and prebiotic in 1:1
(v/v) ratio
30 days Febrianti et al.
(2016)
1609Aquaculture International (2021) 29:1591–1620
investigated. The studies discussed above have reported the ability of probiotic strains in
improving water quality, but the mechanism of action behind this is not yet clear.
Future prospects and conclusion
It is quite clear that we need to address the problems related to the use of antibiotics in
aquaculture, with utmost seriousness. Strict measures have to be taken against the use of
antibiotics in an unscientific way. Most importantly, efforts should be made to educate shrimp
farmers regarding the havocs due to the misuse of chemotherapeutic agents in aquaculture. To
avoid further complications in the future, the use of antibiotics should be minimized as much
as possible.
As many of the commercially available antibiotics are under legislative restrictions in
several countries for aquaculture practices, field application studies to investigate the syner-
gistic combination of phages, nanomaterials, and phytobiotics with antibiotics is difficult
(Culot et al. 2019; Lulijwa et al. 2020). But some of these alternatives can be coupled and
analyzed in aquaculture species for synergistic activities. The use of nanoparticles has im-
proved the rapidness of diagnostic methods, but suitable measures to safely discard them need
to be dealt with in the future. The implications in the microbiome of shrimp pertaining to the
use of nanoparticles for treatment need to be studied apart from its antimicrobial potential to
ensure their reliability as therapeutical agents. Phage display technology has been explored
only against WSSV amongst aquaculture viral pathogens, while there are other emerging
pathogens like IMNV, taura syndrome virus and yellowhead virus where this technology can
merit the diagnosis and therapy.
The immune response of oral vaccines was found to be dissimilar between common carp
and Indian major carps (Azad et al. 1999); whether such disparities can exist with the use of
biofilm-based vaccines in various shrimp varieties demands further research. There is a vast
availability of published data regardingthe applicationof probiotics,synbiotics, nanomaterials,
and algal extracts in the prevention of Vibrio and WSSV infections, while there are no reports
available regarding the application of these in the prevention of other viral, fungal, and
protozoal diseases in shrimp.
Phytobiotics and algal extracts are comparatively safer than antibiotics to be supplemented
in shrimp feed as they are of natural origin. Microorganisms might develop resistance to these
extracts if only one active ingredient is used, which is why natural extracts with multiple active
components are preferred (Gupta and Birdi 2017). There is very limited information in the
literature discussing the possibilities of antimicrobial resistance and pollution of the rearing
system due to the continuous use of natural extracts.
The application of probiotics in aquaculture is a safe and effective solution to control
infectious diseases in shrimp. But the performance of probiotics in disease prevention can be
influenced by many factors like stocking density of shrimp in the pond, the prebiotic factors
required for colonization of probionts, and most importantly, the dosage and frequency of
administration (Ninawe and Selvin 2009). Alongside probiotics have to be stringently evalu-
ated for the presence of antibiotic-resistant genes that could get transmitted to other bacteria
before their commercialization (Moubareck et al. 2005). The application of synbiotics is found
to be superior in improving disease resistance in shrimps rather than probiotics or prebiotics
alone. Different combinations of prebiotics and probiotics can be assessed to identify effective
synbiotics. Moreover, bioencapsulation techniques are adopted to improve the efficacy of
1610 Aquaculture International (2021) 29:1591–1620
synbiotics, but the cost of developing encapsulated synbiotic regimens in large scale needs to
be estimated. The effect of synbiotic diets have been extensively studied in P. vannamei and
whether these diets are useful for other shrimp species lacks clarity. Most of the studies
discussed so far have found novel probiotic strains, phytobiotics, or algal extracts and assayed
their antimicrobial potential against pathogens but molecular mechanisms behind the antimi-
crobial activity are poorly studied, which limits further advancement of these innovations into
commercial markets. Forthcoming studies should try on developing antimicrobial components
targeting a wide range of pathogens. It will also be interesting to find out if the bacterial
pathogens develop resistance to any of these antimicrobial components by performing serial
passage assays.
To conclude, it is quite obvious that antibiotics are no longer a reliable chemotherapeutic
agent in the long-run perspective. There is an increased demand in research to find substitutes
for antibiotics, to fight infectious diseases in shrimp aquaculture. So, far research has come up
with some safe and reliable methods which have remarkable outcomes. Although these
methods have been scientifically proven to be effective, they have not been used extensively
in aquaculture farms. The reason behind it can be accredited to lack of studies conducted on
large scale shrimp farms to examine their efficacy, cost, and after effects. It is needless to say
that these strategies are very effective under laboratory conditions, but that does not guarantee
their efficacy in field environments. These approaches should be subjected to thorough
examination in large scale shrimp farms before commercialization. Considering the pace with
which research has progressed till now, it can be expected that these alternatives play a crucial
role in developing sustainable aquaculture practices in upcoming years.
Acknowledgements The authors are thankful to the Department of Biotechnology, Ministry of Science and
Technology, India, for the research grant.
Author contribution PSS and RR performed the data collection, compilation, and preparation of the first draft;
GSK conceived the concept and guided the literature survey synthesis; JS guided the drafting and correction of
the drafts.
Data availability Not applicable
Declarations
Ethics approval and consent to participate Not applicable
Consent for publication Not applicable
Competing interests The authors declare no competing interests.
References
Acedo-Valdez MR, Grijalva-Chon JM, Larios-Rodríguez E, Maldonado-Arce AD, Mendoza-Cano F, Sánchez-
Paz JA, Castro-Longoria R (2017) Antibacterial effect of biosynthesized silver nanoparticles in Pacific white
shrimp Litopenaeus vannamei (Boone) infected with necrotizing hepatopancreatitis bacterium (NHP-B). Lat
Am J Aquat Res 45:421430. https://doi.org/10.3856/vol45-issue2-fulltext-17
Akhter N, Wu B, Memon AM, Mohsin M (2015) Probiotics and prebiotics associated with aquaculture: A
review. Fish Shellfish Immunol 45:733741. https://doi.org/10.1016/j.fsi.2015.05.038
1611Aquaculture International (2021) 29:1591–1620
Albuquerque Costa R, Araújo RL, Souza OV, Vieira RHSDF (2015) Antibiotic-resistant Vibrios in farmed
shrimp. Biomed Res Int 2015:15. https://doi.org/10.1155/2015/505914
Ali H, Rico A, Murshed-e-Jahan K, Belton B (2016) An assessment of chemical and biological product use in
aquaculture in Bangladesh. Aquaculture 454:199209. https://doi.org/10.1016/j.aquaculture.2015.12.025
Alvarez-Cirerol FJ, López-Torres MA, Rodríguez-León E et al (2019) Silver Nanoparticles Synthesized with
Rumex hymenosepalus: A Strategy to Combat Early Mortality Syndrome (EMS) in a Cultivated White
Shrimp. J Nanomater 2019:8214675. https://doi.org/10.1155/2019/8214675
Amenyogbe E, Chen G, Wang Z, Huang J, Huang B, Li H (2020) The exploitation of probiotics, prebiotics and
synbiotics in aquaculture: present study, limitations and future directions.: a review. Aquac Int 28:1017
1041. https://doi.org/10.1007/s10499-020-00509-0
Arulmoorthy MP, Anandajothi E, Vasudevan S, Suresh E (2020) Major viral diseases in culturable penaeid
shrimps: a review. Aquac Int 28:129. https://doi.org/10.1007/s10499-020-00568-3
Arunrut N, Kampeera J, Sirithammajak S, Sanguanrut P, Proespraiwong P, Suebsing R, Kiatpathomchai W
(2016) Sensitive visual detection of AHPND bacteria using loop-mediated isothermal amplification com-
bined with DNA-functionalized gold nanoparticles as probes. PLoS One 11:e0151769. https://doi.org/10.
1371/journal.pone.0151769
Arunrut N, Kampeera J, Suebsing R, Kiatpathomchai W (2013) Rapid and sensitive detection of shrimp
infectious myonecrosis virus using a reverse transcriptionloop-mediated isothermal amplification and visual
colorogenic nanogold hybridization probe assay. J Virol Methods 193:542547. https://doi.org/10.1016/j.
jviromet.2013.07.017
Azad IS, Shankar KM, Mohan CV, Kalita B (1999) Biofilm vaccine of Aeromonas hydrophilastandardization
of dose and duration for oral vaccination of carps. Fish Shellfish Immunol 9:519528. https://doi.org/10.
1006/fsim.1998.0206
Bahabadi MN, Delavar FH, Mirbakhsh M, Niknam K, Johari SA (2017) Assessment of antibacterial activity of
two different sizes of colloidal silver nanoparticle (cAgNPs) against Vibrio harveyi isolated from shrimp
Litopenaeus vannamei. Aquac Int 25(1):463472. https://doi.org/10.1007/s10499-016-0043-8
Banerjee S, Ooi MC, Shariff M, Khatoon H (2012) Antibiotic resistant Salmonella and Vibrio associated with
farmed Litopenaeus vannamei. Sci World J 2012:16. https://doi.org/10.1100/2012/130136
Blumenthal M (2000) Interactions between herbs and conventional drugs: introductory considerations.
HerbalGram 49:5263
Boinapally K, Jiang X (2007) Comparing antibiotic resistance in commensal and pathogenic bacteria isolated
from wild-caught South Carolina shrimp vs. farm-raised imported shrimp. Can J Microbiol 53:919924.
https://doi.org/10.1139/W07-019
Boonsri N, Rudtanatip T, Withyachumnarnkul B, Wongprasert K (2017) Protein extract from red seaweed
Gracilaria fisheri prevents acute hepatopancreatic necrosis disease (AHPND) infection in shrimp. J Appl
Phycol 29:15971608. https://doi.org/10.1007/s10811-016-0969-2
Bowman DM (2017) More than a decade on: mapping todays regulatory and policy landscapes following the
publication of nanoscience and nanotechnologies: opportunities and uncertainties. NanoEthics 11:169186.
https://doi.org/10.1007/s11569-017-0281-x
Bron PA, Van Baarlen P, Kleerebezem M (2012) Emerging molecular insights into the interaction between
probiotics and the host intestinal mucosa. Nat Rev Microbiol 10:6678. https://doi.org/10.1038/nrmicro2690
Cahyadi J, Satriani GI, Gusman E, Weliyadi E (2020) Inhibiting Vibrio harveyi infection in Penaeus monodon
using enriched Artemia salina with mangrove fruit Sonneratia alba extract. AACL Bioflux 13:16741681
Cai Y, Yuan W, Wang S, Guo W, Li A, Wu Y, Chen X, Ren Z, Zhou Y (2019) In vitro screening of putative
probiotics and their dual beneficial effects: To white shrimp (Litopenaeus vannamei) postlarvae and to the
rearing water. Aquaculture 498:6171. https://doi.org/10.1016/j.aquaculture.2018.08.024
Camacho-Jiménez L, Álvarez-Sánchez AR, Mejía-Ruíz CH (2020) Silver nanoparticles (AgNPs) as antimicro-
bials in marine shrimp farming: A review. Aquacult Rep 18:100512. https://doi.org/10.1016/j.aqrep.2020.
100512
Carvalho FC, Sousa OV, Carvalho EM, Hofer E, Vieira RH (2013) Antibiotic resistance of Salmonella spp.
isolated from shrimp farming freshwater environment in Northeast region of Brazil. J Pathog 2013:685193.
https://doi.org/10.1155/2013/685193
Cerezuela R, Meseguer J, Esteban MA (2011) Current knowledge in synbiotic use for fish aquaculture: a review.
J Aquacult Res Develop S1:17. https://doi.org/10.4172/2155-9546.S1-008
Chai PC, Song XL, Chen GF, Xu H, Huang J (2016) Dietary supplementation of probiotic Bacillus PC465
isolated from the gut of Fenneropenaeus chinensis improves the health status and resistance of Litopenaeus
vannamei against white spot syndrome virus. Fish Shellfish Immunol 54:602611. https://doi.org/10.1016/j.
fsi.2016.05.011
1612 Aquaculture International (2021) 29:1591–1620
Chakraborty SB, Hancz C (2011) Application of phytochemicals as immunostimulant, antipathogenic and
antistress agents in finfish culture. Rev Aquac 3:103119. https://doi.org/10.1111/j.1753-5131.2011.
01048.x
Chalamcherla VL (2015) Nano Vaccines: New Paradigm in Aqua Health Sector. J Aquacult Marine Biol 33:
e00061. https://doi.org/10.15406/jamb.2015.03.00061
Chari N, Felix L, Davoodbasha M, Ali AS, Nooruddin T (2017) In vitro and in vivo antibiofilm effect of copper
nanoparticles against aquaculture pathogens. Biocatal Agricult Biotechnol 10:336341. https://doi.org/10.
1016/j.bcab.2017.04.013
Cheng G, Hao H, Xie S, Wang X, Dai M, Huang L, Yuan Z (2014) Antibiotic alternatives: the substitution of
antibiotics in animal husbandry? Front Microbiol 5:217. https://doi.org/10.3389/fmicb.2014.00217
Chi TTK, Clausen JH, Van PT, Tersbøl B, Dalsgaard A (2017) Use practices of antimicrobials and other
compounds by shrimp and fish farmers in Northern Vietnam. Aquacult Rep 7:4047. https://doi.org/10.
1016/j.aqrep.2017.05.003
Chumpol S, Kantachote D, Nitoda T, Kanzaki H (2017) The roles of probiotic purple nonsulfur bacteria to
control water quality and prevent acute hepatopancreatic necrosis disease (AHPND) for enhancement
growth with higher survival in white shrimp (Litopenaeus vannamei) during cultivation. Aquaculture 473:
327336. https://doi.org/10.1016/j.aquaculture.2017.02.033
Culot A, Grosset N, Gautier M (2019) Overcoming the challenges of phage therapy for industrial aquaculture: A
review. Aquaculture 513:734423. https://doi.org/10.1016/j.aquaculture.2019.734423
Dash P, Avunje S, Tandel RS, Sandeep KP, Panigrahi A (2017) Biocontrol of luminous vibriosis in shrimp
aquaculture: a review of current approaches and future perspectives. Rev Fisher Sci Aquacult 25:245255.
https://doi.org/10.1080/23308249.2016.1277973
Dashtiannasab A, Mesbah M, Pyghan R, Kakoolaki S (2016) The efficacy of the red seaweed (Laurencia
snyderiae) extract on growth performance, survival and disease resistance in white shrimp. Iran J Aquatic
Animal Health 2:110. https://doi.org/10.18869/acadpub.ijaah.2.1.1
Decamp O, Moriarty DJ, Lavens P (2008) Probiotics for shrimp larviculture: review of field data from Asia and
Latin America. Aquac Res 39:334338. https://doi.org/10.1111/j.1365-2109.2007.01664.x
Defoirdt T, Boon N, Bossier P, Verstraete W (2004) Disruption of bacterial quorum sensing: an unexplored
strategy to fight infections in aquaculture. Aquaculture 240:6988. https://doi.org/10.1016/j.aquaculture.
2004.06.031
Dong X, Song J, Chen J, Bi D, Wang W, Ren Y, Wang H, Wang G, Tang KFJ, Wang X, Huang J (2019)
Conjugative transfer of the pVA1-type plasmid carrying the pirABvp genes results in the formation of new
AHPND-causing Vibrio. Front Cell Infect Microbiol 9:195. https://doi.org/10.3389/fcimb.2019.00195
Dy RL, Rigano LA, Fineran PC (2018) Phage-based biocontrol strategies and their application in agriculture and
aquaculture. Biochem Soc Trans 46:16051613. https://doi.org/10.1042/BST20180178
Elumalai P, Kurian A, Lakshmi S, Faggio C, Esteban MA, Ringø E (2020) Herbal immunomodulators in
aquaculture. Rev Fisher Sci Aquacult 29:125. https://doi.org/10.1080/23308249.2020.1779651
FAO (2019) FAO yearbook. In: Fishery and Aquaculture Statistics 2017
Febrianti D, Yuhana M (2016) Dietary synbiotic microcapsule influence the immune responses, growth
performance and microbial populations to white spot syndrome virus in pacific white shrimp (Litopenaeus
vannamei). J Fish Aquat Sci 11:2842. https://doi.org/10.3923/jfas.2016.28.42
Gholamhosseini A, Kheirandish MR, Shiry N, Akhlaghi M, Soltanian S, Roshanpour H, Banaee M (2020) Use
of a methanolic olive leaf extract (Olea europaea) against white spot virus syndrome in Penaeus vannamei:
Comparing the biochemical, hematological and immunological changes. Aquaculture 528:735556. https://
doi.org/10.1016/j.aquaculture.2020.735556
Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the
concept of prebiotics. J Nutr 125:14011412. https://doi.org/10.1093/jn/125.6.1401
Gunathilaka GU, Tahlan V, Mafiz AI, Polur M, Zhang Y (2017) Phages in urban wastewater have the potential
to disseminate antibiotic resistance. Int J Antimicrob Agents 50:678683. https://doi.org/10.1016/j.
ijantimicag.2017.08.013
Gupta PD, Birdi TJ (2017) Development of botanicals to combat antibiotic resistance. J Ayurveda Integr Med
8(4):266275. https://doi.org/10.1016/j.jaim.2017.05.004
Hai NV, Fotedar R (2009) Comparison of the effects of the prebiotics (Bio-Mos® and β-1, 3-D-glucan) and the
customised probiotics (Pseudomonas synxantha and P. aeruginosa) on the culture of juvenile western king
prawns (Penaeus latisulcatus Kishinouye, 1896). Aquaculture 289:310316. https://doi.org/10.1016/j.
aquaculture.2009.02.001
Hai NV, Fotedar R (2010) A review of probiotics in shrimp aquaculture. J Appl Aquac 22:251266. https://doi.
org/10.1080/10454438.2010.500597
1613Aquaculture International (2021) 29:1591–1620
Hamsah H, Widanarni W, Alimuddin A, Yuhana M, Junior MZ, Hidayatullah D (2019) Immune response and
resistance of Pacific white shrimp larvae administered probiotic, prebiotic, and synbiotic through the bio-
encapsulation of Artemia sp. Aquac Int 27:567580. https://doi.org/10.1007/s10499-019-00346-w
Harpeni E, Santoso L, Supono S, Wardiyanto W, Widodo A, Yolanda L (2017) Effects of dietary probiotic
Bacillus sp. D2. 2 and prebiotic sweet potato extract on growth performance and resistance to Vibrio harveyi
in Pacific white shrimp, Litopenaeus vannamei. Aquacult Indonesiana 18:5561. https://doi.org/10.21534/ai.
v18i2.107
Havenaar R, Huis Int Veld JHJ (1992) Probiotics: A General View. In: Wood BJB (ed) The Lactic Acid
Bacteria, vol 1. Springer, Berlin, pp 151170. https://doi.org/10.1007/978-1-4615-3522-5_6
Holmström K, Gräslund S, Wahlström A, Poungshompoo S, Bengtsson BE, Kautsky N (2003) Antibiotic use in
shrimp farming and implications for environmental impacts and human health. Int J Food Sci Technol 38:
255266. https://doi.org/10.1046/j.1365-2621.2003.00671.x
Hoseinifar S, Zare P, Kolangi Miandare H (2015) The effects of different routes of inulin administration on gut
microbiota and survival rate of Indian white shrimp post-larvae (Fenneropenaeus indicus). Vet Res Forum 6:
331335
Howlader P, Ghosh AK, Islam SS, Bir J, Banu GR (2020) Antiviral activity of Cynodon dactylon on white spot
syndrome virus (WSSV)-infected shrimp: an attempt to mitigate risk in shrimp farming. AquacInt 28:1725
1738. https://doi.org/10.1007/s10499-020-00553-w
Huang X, Zhou H, Zhang H (2006) The effect of Sargassum fusiforme polysaccharide extracts on vibriosis
resistance and immune activity of the shrimp, Fenneropenaeus chinensis. Fish Shellfish Immunol 20:750
757. https://doi.org/10.1016/j.fsi.2005.09.008
Hubschman JH, Schmitt JA (1969) Primary mycosis in shrimp larvae. J Invertebr Pathol 13:351357. https://doi.
org/10.1016/0022-2011(69)90186-4
Huynh TG, Cheng AC, Chi CC, Chiu KH, Liu CH (2018a) A synbiotic improves the immunity of white shrimp,
Litopenaeus vannamei: Metabolomic analysis reveal compelling evidence. Fish Shellfish Immunol 79:284
293. https://doi.org/10.1016/j.fsi.2018.05.031
Huynh TG, Chi CC, Nguyen TP, Tran TTTH, Cheng AC, Liu CH (2018b) Effects of synbiotic containing
Lactobacillus plantarum 740 and galactooligosaccharide on the growth performance of white shrimp,
Litopenaeus vannamei. Aquac Res 49:24162428. https://doi.org/10.1111/are.13701
Huynh TG, Yeh ST, Lin YC, Shyu JF, Chen LL, Chen JC (2011) White shrimp Litopenaeus vannamei immersed
in seawater containing Sargassum hemiphyllum var. chinense powder and its extract showed increased
immunity and resistance against Vibrio alginolyticus and White spot syndrome virus. Fish Shellfish
Immunol 31:286293. https://doi.org/10.1016/j.fsi.2011.05.014
Hyman P, Abedon ST (2010) Bacteriophage host range and bacterial resistance. In: Laskin AI (ed) Advances in
Applied Microbiology, vol 70. Academic Press, Cambridge, pp 217248. https://doi.org/10.1016/S0065-
2164(10)70007-1
Ibañez E, Herrero M, Mendiola JA, Castro-Puyana M (2012) Extraction and characterization of bioactive
compounds with health benefits from marine resources: macro and micro algae, cyanobacteria, and
invertebrates. In: Hayes M (ed) Marine Bioactive Compounds. Springer, Berlin. https://doi.org/10.1007/
978-1-4614-1247-2_2
Immanuel G, Sivagnanavelmurugan M, Marudhupandi T, Radhakrishnan S, Palavesam A (2012) The effect of
fucoidan from brown seaweed Sargassum wightii on WSSV resistance and immune activity in shrimp
Penaeus monodon (Fab). Fish Shellfish Immunol 32:551564. https://doi.org/10.1016/j.fsi.2012.01.003
Interaminense JA, Vogeley JL, Gouveia CK, Portela RW, Oliveira JP, Andrade HA, Bezerra RS (2018) In vitro
and in vivo potential probiotic activity of Bacillus subtilis and Shewanella algaeforuseinLitopenaeus
vannamei rearing. Aquaculture 488:114122. https://doi.org/10.1016/j.aquaculture.2018.01.027
Irianto A, Austin B (2002) Probiotics in aquaculture. J Fish Dis 25:633642. https://doi.org/10.1046/j.1365-
2761.2002.00422.x
Itami T, Asano M, Tokushige K, Kubono K, Nakagawa A, Takeno N, Nishimura H, Maeda M, Kondo M,
Takahashi Y (1998) Enhancement of disease resistance of kuruma shrimp, Penaeus japonicus, after oral
administration of peptidoglycan derived from Bifidobacterium thermophilum. Aquaculture 164:277288.
https://doi.org/10.1016/S0044-8486(98)00193-8
Jana P, Karmakar S, Roy U, Paul M, Bera AKSKK (2018) Phytobiotics in aquaculture health management: A
review. J Entomol Zool Stud 6:14221429
Jaroenram W, Arunrut N, Kiatpathomchai W (2012) Rapid and sensitive detection of shrimp yellow head virus
using loop-mediated isothermal amplification and a colorogenic nanogold hybridization probe. J Virol
Methods 186:3642. https://doi.org/10.1016/j.jviromet.2012.08.013
Juárez-Moreno K, Mejía-Ruiz CH, Díaz F et al (2017) Effect of silver nanoparticles on the metabolic rate,
hematological response, and survival of juvenile white shrimp Litopenaeus vannamei. Chemosphere 169:
716724. https://doi.org/10.1016/j.chemosphere.2016.11.054
1614 Aquaculture International (2021) 29:1591–1620
Jun JW, Han JE, Giri SS, Tang KFJ, Zhou X, Aranguren LF, Kim HJ, Yun S, Chi C, Kim SG, Park SC (2018)
Phage application for the protection from acute hepatopancreatic necrosis disease (AHPND) in Penaeus
vannamei. Indian J Microbiol 58:114117. https://doi.org/10.1007/s12088-017-0694-9
Jun JW, Han JE, Tang KF, Lightner DV, KimJ, Seo SW, Park SC (2016) Potential application of bacteriophage
pVp-1: agent combating Vibrio parahaemolyticus strains associated with acute hepatopancreatic necrosis
disease (AHPND) in shrimp. Aquaculture 457:100103. https://doi.org/10.1016/j.aquaculture.2016.02.018
Kalatzis PG, Bastías R, Kokkari C, Katharios P (2016) Isolation and characterization of two lytic bacteriophages,
φSt2 and φGrn1; phage therapy application for biological control of Vibrio alginolyticus in aquaculture live
feeds. PLoS One 11:e0151101. https://doi.org/10.1371/journal.pone.0151101
Kandasamy K, Alikunhi NM, Manickaswami G, Nabikhan A, Ayyavu G (2013) Synthesis of silver nanoparticles
by coastal plant Prosopis chilensis (L.) and their efficacy in controlling vibriosis in shrimp Penaeus
monodon. Appl Nanosci 3:6573. https://doi.org/10.1007/s13204-012-0064-1
Karnjana K, Soowannayan C, Wongprasert K (2019) Ethanolic extract of red seaweed Gracilaria fisheri and
furanone eradicate Vibrio harveyi and Vibrio parahaemolyticus biofilms and ameliorate the bacterial
infection in shrimp. Fish Shellfish Immunol 88:91101. https://doi.org/10.1016/j.fsi.2019.01.058
Karunasagar I, OttaSK, Karunasagar I (1996) Biofilm formation by Vibrio harveyi on surfaces. Aquaculture 140:
241245. https://doi.org/10.1016/0044-8486(95)01180-3
Karunasagar I, Pai R, Malathi GR, Karunasagar I (1994) Mass mortality of Penaeus monodon larvae due to
antibiotic-resistant Vibrio harveyi infection. Aquaculture 128:203209. https://doi.org/10.1016/0044-
486(94)90309-3
Keen EC, Bliskovsky VV, Malagon F, Baker JD, Prince JS, Klaus JS, Adhya SL (2017) Novel Superspreader
Bacteriophages Promote Horizontal Gene Transfer by Transformation. mBio 8:e02115e02116. https://doi.
org/10.1128/mBio.02115-16
Kewcharoen W, Srisapoome P (2019) Probiotic effects of Bacillus spp. from Pacific white shrimp (Litopenaeus
vannamei) on water quality and shrimp growth, immune responses, and resistance to Vibrio
parahaemolyticus (AHPND strains). Fish Shellfish Immunol 94:175189. https://doi.org/10.1016/j.fsi.
2019.09.013
Khademzade O, Zakeri M, Haghi M, Mousavi SM (2020) The effects of water additive Bacillus cereus and
Pediococcus acidilactici on water quality, growth performances, economic benefits, immunohematology
and bacterial flora of whiteleg shrimp (Penaeus vannamei Boone, 1931) reared in earthen ponds. Aquac Res
51:17591770. https://doi.org/10.1111/are.14525
Kitiyodom S, Khemtong S, Wongtavatchai J, Chuanchuen R (2010) Characterization of antibiotic resistance in
Vibrio spp. isolated from farmed marine shrimp (Penaeus monodon). FEMS Microbiol Ecol 72:219227.
https://doi.org/10.1111/j.1574-6941.2010.00846.x
Klongklaew N, Praiboon J, Tamtin M, Srisapoome P (2020) Antibacterial and antiviral activities of local Thai
green macroalgae crude extracts in pacific white shrimp (Litopenaeus vannamei). Marine drugs 18:140.
https://doi.org/10.3390/md18030140
Kobayashi M, Msangi S, Batka M, Vannuccini S, Dey MM, Anderson (2015) Fish to 2030: the role and
opportunity for aquaculture. Aquac Econ Manag 19:282300. https://doi.org/10.1080/13657305.2015.
994240
Krylov VN (2001) Phage therapy in terms of bacteriophage genetics: hopes, prospects, safety, limitations. Russ J
Genet 37:715730. https://doi.org/10.1023/A:1016716606135
Laanto E, Mäkelä K, Hoikkala V, Ravantti JJ, Sundberg LR (2020) Adapting a Phage to Combat Phage
Resistance. Antibiot 9:291. https://doi.org/10.3390/antibiotics9060291
Lai HC, Ng TH, Ando M, Lee CT, Chen IT, Chuang JC, Mavichak R, Chang SH, Yeh MD, Chiang YA,
Takeyama H, Hamaguchi HO, Lo CF, Aoki T, Wang HC (2015) Pathogenesis of acute hepatopancreatic
necrosis disease (AHPND) in shrimp. Fish Shellfish Immunol 47:10061014. https://doi.org/10.1016/j.fsi.
2015.11.008
Le B, Yang SH (2018) Probiotic potential of novel Lactobacillus strains isolated from salted-fermented shrimp as
antagonists for Vibrio parahaemolyticus. J Microbiol 56:138144. https://doi.org/10.1007/s12275-018-
7407-x
Le TX, Munekage Y, Kato SI (2005) Antibiotic resistance in bacteria from shrimp farming in mangrove areas.
Sci Total Environ 349:95105. https://doi.org/10.1016/j.scitotenv.2005.01.006
Lee CL, Kuo HW,Chang CC, Cheng W (2020) Injection of an extract offresh cacao pod husks into Litopenaeus
vannamei upregulates immune responses via innate immune signaling pathways. Fish Shellfish Immunol
104:545556. https://doi.org/10.1016/j.fsi.2020.05.070
Li L, Lin SL, Deng L, Liu ZG (2013) Potential use of chitosan nanoparticles for oral delivery of DNA vaccine in
black seabream Acanthopagrus schlegelii Bleeker to protect from Vibrio parahaemolyticus.JFishDis36:
987995. https://doi.org/10.1111/jfd.12032
1615Aquaculture International (2021) 29:1591–1620
Li P, Burr GS, Gatlin DM III, Hume ME, Patnaik S, Castille FL, Lawrence AL (2007) Dietary supplementation
of short-chain fructooligosaccharides influences gastrointestinal microbiota composition and immunity
characteristics of Pacific white shrimp, Litopenaeus vann amei, cultured in a recirculating system. J Nutr
137:27632768. https://doi.org/10.1093/jn/137.12.2763
Li Y, Liu H, Dai X, Li J, Ding F (2018) Effects of dietary inulin and mannan oligosaccharide on immune related
genes expression and disease resistance of Pacific white shrimp, Litopenaeus vannamei.FishShellfish
Immunol 76:7892. https://doi.org/10.1016/j.fsi.2018.02.034
Lightner DV, Redman RM (1998) Shrimp diseases and current diagnostic methods. Aquaculture 164:201220.
https://doi.org/10.1016/S0044-8486(98)00187-2
Liu CH, Chen JC (2004) Effect of ammonia on the immune response of white shrimp Litopenaeus vannamei and
its susceptibility to Vibrio alginolyticus. Fish Shellfish Immunol 16:321334. https://doi.org/10.1016/S1050-
4648(03)00113-X
Logambal SM, Venkatalakshmi S, Michael RD (2000) Immunostimulatory effect of leaf extract of Ocimum
sanctum Linn. in Oreochromis mossambicus (Peters). Hydrobiologia 430:113120. https://doi.org/10.1023/
A:1004029332114
Lomelí-Ortega CO, Martínez-Díaz SF (2014) Phage therapy against Vibrio parahaemolyticus infectioninthe
whiteleg shrimp (Litopenaeus vannamei) larvae. Aquaculture 434:208211. https://doi.org/10.1016/j.
aquaculture.2014.08.018
Luis AIS, Campos EVR, de Oliveira JL, Fraceto LF (2019) Trends in aquaculture sciences: from now to use of
nanotechnology for disease control. Rev Aquac 11:119132. https://doi.org/10.1111/raq.12229
Lulijwa R, Rupia EJ, Alfaro AC (2020) Antibiotic use in aquaculture, policies and regulation, health and
environmental risks: a review of the top 15 major producers. Rev Aquac 12:640663. https://doi.org/10.
1111/raq.12344
Ma CW, Cho YS, Oh KH (2009) Removal of pathogenic bacteria and nitrogens by Lactobacillus spp. JK-8 and
JK-11. Aquaculture 287:266270. https://doi.org/10.1016/j.aquaculture.2008.10.061
Ma Y, Chen L, Fan J, Yan T, Liu Q, Yuan S, Deng D (2019) Isolationand characterization ofspecific phages to
prepare a cocktail preventing Vibrio sp. Va-F3 infections in shrimp (Litopenaeus vannamei). Front
Microbiol 10:2337. https://doi.org/10.3389/fmicb.2019.02337
Makarov R, Lomelí-Ortega CO, Zermeño-Cervantes LA, García-Álvarez E, Gutiérrez-Rivera JN, Cardona-Félix
CS, Martínez-Díaz SF (2019) Evaluation of a cocktail of phages for the control of presumptive Vibrio
parahaemolyticus strains associated to acute hepatopancreatic necrosis disease. Aquac Res 50:31073116.
https://doi.org/10.1111/are.14258
Maldonado-Muñiz M, Luna C, Mendoza-Reséndez R, Barriga-Castro ED, Soto-Rodriguez S, Ricque-Marie D,
Cruz-Suarez LE (2020) Silver nanoparticles against acute hepatopancreatic necrosis disease (AHPND) in
shrimp and their depuration kinetics. J Appl Phycol 32:24312445. https://doi.org/10.1007/s10811-019-
01948-w
Mamun MAA, Nasren S, Abhiman PB, Rathore SS, Sowndarya NS, Ramesh KS, Shankar KM (2019)
Investigation of production, formation and characterization of biofilm cells of Aeromonas hydrophila for
oral vaccination of fish. J Experiment Zool India 22:11151123
Manik H, Solin M, Thami K, Al Fajar B (2020) Fortification of chitosan and mangrove flour as windu shrimp
feed (Penaeus monodon)against infection white spot syndrome virus. IOP Confer Ser: Mater Sci Eng 725:
012071. https://doi.org/10.1088/1757-899X/725/1/012071
Manilal A, Sujith S, Kiran GS, Selvin J, Shakir C, Gandhimathi R, Lipton AP (2009) Antimicrobial potential and
seasonality of red algae collected from the southwest coast of India tested against shrimp, human and
phytopathogens. Ann Microbiol 59:207219. https://doi.org/10.1007/BF03178319
Mateus L, Costa L, Silva YJ, Pereira C, Cunha A, Almeida A (2014) Efficiency of phage cocktails in the
inactivation of Vibrio in aquaculture. Aquaculture 424:167173. https://doi.org/10.1016/j.aquaculture.2014.
01.001
Mavichak R, Takano T, Kondo H, Hirono I, Wada S, Hatai K, Inagawa H, Takahashi Y, Yoshimura T, Kiyono
H, Yuki Y, Aoki T (2010) The effect of liposome-coated recombinant protein VP28 against white spot
syndrome virus in kuruma shrimp, Marsupenaeus japonicus. J Fish Dis 33:6974. https://doi.org/10.1111/j.
1365-2761.2009.01090.x
Mazón-Suástegui JM, Salas-Leiva JS, Medina-Marrero R, Medina-García R, García-Bernal M (2019) Effect of
Streptomyces probiotics on the gut microbiota of Litopenaeus vannamei challenged with Vibrio
parahaemolyticus. MicrobiologyOpen 9:e967. https://doi.org/10.1002/mbo3.967
Melo LMRD, Almeida D, Hofer E, Reis CMFD, Theophilo GND, Santos AFDM, Vieira RHSDF (2011)
Antibiotic resistance of Vibrio parahaemolyticus isolated from pond-reared Litopenaeus vannamei marketed
in Natal, Brazil. Braz J Microbiol 42:14631469. https://doi.org/10.1590/S1517-83822011000400032
1616 Aquaculture International (2021) 29:1591–1620
Meneses-Márquez JC, Hamdan-Partida A, del Carmen M-DM, Castro-Mejía J, Faustino-Vega A, Soria-Castro E,
Bustos-Martínez J (2019) Use of silver nanoparticles to control Vibrio fluvialis in cultured angelfish
Pterophyllum scalare. Dis Aquat Org 137:6572. https://doi.org/10.3354/dao03423
Moges FD, Patel P, Parashar SKS, Das B (2020) Mechanistic insights into diverse nano-based strategies for
aquaculture enhancement: A holistic review. Aquaculture 519:734770. https://doi.org/10.1016/j.aquaculture.
2019.734770
Molina-Aja A, García-Gasca A, Abreu-Grobois A, Bolán-Mejía C, Roque A, Gomez-Gil B (2002) Plasmid
profiling and antibiotic resistance of Vibrio strains isolated from cultured penaeid shrimp. FEMS Microbiol
Lett 213:712. https://doi.org/10.1016/S0378-1097(02)00791-7
Moubareck C, Gavini F, Vaugien L, Butel MJ, Doucet-Populaire F (2005) Antimicrobial susceptibility of
bifidobacteria. J Antimicrob Chemother 55:3844. https://doi.org/10.1093/jac/dkh495
Moustafa EM, Saad TT, Khalil RH, Dawood MAO, Lolo EE (2020) The ameliorative role of synbiotic culture
techniques application in white shrimp (Litopenaeus vannamei) during nursery stage. Adv Animal Vet Sci 8:
260277. https://doi.org/10.17582/journal.aavs/2020/8.3.260.277
Munaeni W, Yuhana M, Setiawati M, Wahyudi AT (2020) Effect in white shrimp Litopenaeus vannamei of
Eleutherine bulbosa (Mill.) Urb. Powder on immune genes expression and resistance against Vibrio
parahaemolyticus infection. Fish Shellfish Immunol 102:218227. https://doi.org/10.1016/j.fsi.2020.03.066
Munaeni W, Yuhana M, Widanarni W (2014) Effect of micro-encapsulated synbiotic at different frequencies for
luminous vibriosis control in white shrimp (Litopenaeus vannamei). Microbiol Indonesia 8:580. https://doi.
org/10.5454/mi.8.2.5
Nakai T (2010) Application of Bacteriophages for Control of Infectious Diseases in Aquaculture. In: Sabour P,
Griffiths M (eds) Bacteriophages in the Control of Food-and Waterborne Pathogens, vol 153. ASM Press,
Washington, DC, pp 257272. https://doi.org/10.1016/S0923-2508(01)01280-3
Nakai T, Park SC (2002) Bacteriophage therapy of infectious diseases in aquaculture. Res Microbiol 153:1318.
https://doi.org/10.1016/S0923-2508(01)01280-3
Nakai T, Sugimoto R, Park KH, Matsuoka S, Mori KI, Nishioka T, Maruyama K (1999) Protective effects of
bacteriophage on experimental Lactococcus garvieae infection in yellowtail. Dis Aquat Org 37:3341.
https://doi.org/10.3354/dao037033
Nakayama T, Ito E, Nomura N, Nomura N, Matsumura M (2006) Comparison of Vibrio harveyi strains isolated
from shrimp farms and from culture collection in terms of toxicity and antibiotic resistance. FEMS Microbiol
Lett 258:194199. https://doi.org/10.1111/j.1574-6968.2006.00225.x
Nasir A, Kausar A, Younus A (2015) A review on preparation, properties and applications of polymeric
nanoparticle-based materials. Polym-Plast Technol Eng 54:325341. https://doi.org/10.1080/03602559.
2014.958780
Nealson KH, Platt T, Hastings JW (1970) Cellular control of the synthesis and activity of the bacterial
luminescent system. J Bacteriol 104:313322. https://doi.org/10.1128/JB.104.1.313-322.1970
Nga BT, Lürling MFLLW, Peeters ETHM, Roijackers R, Scheffer M, Nghia TT (2005) Chemical and physical
effects of crowding on growth and survival of Penaeus monodon Fabricius post-larvae. Aquaculture 246:
455465. https://doi.org/10.1016/j.aquaculture.2005.02.026
Nikapitiya C, Dananjaya SHS, Edirisinghe SL, Chandrarathna HPSU, Lee J, De Zoysa M (2020) Development
of phage delivery by bioencapsulation of artemia nauplii with Edwardsiella tarda phage (ETP-1). Braz J
Microbiol 51:21532162. https://doi.org/10.1007/s42770-020-00324-y
Nimrat S, Khaopong W, Sangsong J, Boonthai T, Vuthiphandchai V (2019) Dietary administration of Bacillus
and yeast probiotics improves the growth, survival, and microbial community of juvenile whiteleg shrimp,
Litopenaeus vannamei. J Appl Aquac:117. https://doi.org/10.1080/10454438.2019.1655517
Ninawe AS, Selvin J (2009) Probiotics in shrimp aquaculture: avenues and challenges. Crit Rev Microbiol 35:
4366. https://doi.org/10.1080/10408410802667202
Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T (2000) Loop-mediated
isothermal amplification of DNA. Nucleic Acids Res 28:e63. https://doi.org/10.1093/nar/28.12.e63
Nurhajati J, Aryantha INP, Indah DG (2012) The curative action of Lactobacillus plantarum FNCC 226 to
Saprolegnia parasitica A3 on catfish (Pangasius hypophthalamus Sauvage). Int Food Res J 19:17231727
Oktaviana A, Widanarni W, Yuhana M (2014) The use of synbiotics to prevent IMNV and Vibrio harveyi co-
infection in Litopenaeus vannamei. HAYATI J Biosci 21(3):127134. https://doi.org/10.4308/hjb.21.3.127
Oliveira H, Sillankorva S, Merabishvili M, Kluskens LD, Azeredo J (2015) Unexploited opportunities for phage
therapy. Front Pharmacol 6:180. https://doi.org/10.3389/fphar.2015.00180
Oliveira J, Castilho F, Cunha A, Pereira MJ (2012) Bacteriophage therapy as a bacterial control strategy in
aquaculture. Aquac Int 20:879910. https://doi.org/10.1007/s10499-012-9515-7
Olusola SE, Emikpe BO, Olaifa FE (2013) The potentials of medicinal plant extracts as bio-antimicrobials in
aquaculture. Int J Med Aromatic Plants 3:e412
1617Aquaculture International (2021) 29:1591–1620
Palanikumar P, Wahjuningrum D, Abinaya P, Babu MM, Citarasu T (2020) Usage of plant natural products for
prevention and control of white feces syndrome (WFS) in Pacific whiteleg shrimp Litopenaeus vannamei
farming in India. Aquac Int 28:113125. https://doi.org/10.1007/s10499-019-00448-5
Palanisamy S, Anjali R, Rajasekar P, Kannapiran E, Vaseeharan B, Prabhu NM (2017) Synthesis and
Distribution of Bioinspired Silver Nanoparticles Using Spirulina Extract for Control of Vibrio
parahaemolyticus Infection in Aquaculture. Asian J Chem 29:e20335. https://doi.org/10.14233/ajchem.
2017.20335
Pantjara B, Kristanto AH (2020) Pond bottom management and probiotic application in extensive Tiger prawn
(Penaeus monodon) culture on acid sulfate soil. AACL Bioflux 13:974983
Prada-Peñaranda C, Salazar M, Güiza L, Pérez MI, Leidy C, Vives-Florez MJ (2018) Phage preparation FBL1
prevents Bacillus licheniformis biofilm, bacterium responsible for the mortality of the Pacific White Shrimp
Litopenaeus vannamei. Aquaculture 484:160167. https://doi.org/10.1016/j.aquaculture.2017.11.007
Pradhan D, Flaherty M (2007) National initiatives, local effects: trade liberalization, shrimp aquaculture, and
coastal communities in Orissa, India. Soc Nat Resour 21:6376. https://doi.org/10.1080/
08941920701655734
Prasad KP, Shyam KU, Banu H, Jeena K, Krishnan R (2017) Infectious Myonecrosis Virus (IMNV)An
alarming viral pathogen to Penaeid shrimps. Aquaculture 477:99105. https://doi.org/10.1016/j.
aquaculture.2016.12.021
Rajeev R, Adithya KK, Kiran GS, Selvin J (2021) Healthy microbiome: a key to successful and sustainable
shrimp aquaculture. Rev Aquac 13:238258. https://doi.org/10.1111/raq.12471
Rajendran KV, Shivam S, Praveena PE et al (2016) Emergence of Enterocytozoon hepatopenaei (EHP) in
farmed Penaeus (Litopenaeus)vannamei in India. Aquaculture 454:272280. https://doi.org/10.1016/j.
aquaculture.2015.12.034
Rajeshkumar S, Venkatesan C, Sarathi M, Sarathbabu V, Thomas J, Basha KA, Hameed AS (2009) Oral
delivery of DNA construct using chitosan nanoparticles to protect the shrimp from white spot syndrome
virus (WSSV). Fish Shellfish Immunol 26:429437. https://doi.org/10.1016/j.fsi.2009.01.003
Ramamoorthy S, Kannaiyan P, Moturi M et al (2013) Antibacterial activity of zinc oxide nanoparticles against
Vibrio harveyi. Indian J Fish 60:107112
RathnaKumari P, Kolanchinathan P, Siva D, Abirami B, Masilamani V, John G, Achiraman S, Balasundaram A
(2018) Antibacterial efficacy of seagrass Cymodocea serrulate engineered silver nanoparticles against prawn
pathogen Vibrio parahaemolyticus and its combative effect on the marine shrimp Penaeus monodon.
Aquaculture 493:158164. https://doi.org/10.1016/j.aquaculture.2018.04.061
Reverter M, Sarter S, Caruso D, Avarre JC, Combe M, Pepey E, Pouyaud L, Vega-Heredía S, de Verdal H,
Gozlan RE (2020) Aquaculture at the crossroads of global warming and antimicrobial resistance. Nat
Commun 11:18. https://doi.org/10.1038/s41467-020-15735-6
Reverter M, Tapissier-Bontemps N, Sarter S, Sasal P, Caruso D (2021) Moving towards more sustainable
aquaculture practices: a meta-analysis on the potential of plant-enriched diets to improve fish growth,
immunity and disease resistance. Rev Aquac 13:537555. https://doi.org/10.1111/raq.12485
Romo-Quiñonez CR, Álvarez-Sánchez AR, Álvarez-Ruiz P, Chávez-Sánchez MC, Bogdanchikova N,
Pestryakov A, Mejia-Ruiz CH (2020) Evaluation of a new Argovit as an antiviral agent included in feed
to protect the shrimp Litopenaeus vannamei against white Spot Syndrome Virus infection. PeerJ 8:e8446.
https://doi.org/10.7717/peerj.8446
Ross RP, Desmond C, Fitzgerald GF, Stanton C (2005) Overcoming the technological hurdles in the develop-
ment of probiotic foods. J Appl Microbiol 98:14101417. https://doi.org/10.1111/j.1365-2672.2005.02654.x
Rungrassamee W, Kingcha Y, Srimarut Y, Maibunkaew S, Karoonuthaisiri N, Visessanguan W (2014)
Mannooligosaccharides from copra meal improves survival of the Pacific white shrimp (Litopenaeus
vannamei) after exposure to Vibrio harveyi. Aquaculture 434:403410. https://doi.org/10.1016/j.
aquaculture.2014.08.032
Sakai M (1999) Current research status of fish immunostimulants. Aquaculture 172:6392. https://doi.org/10.
1016/S0044-8486(98)00436-0
Sánchez-Martínez JG, Aguirre-Guzmán G, Mejía-Ruíz H (2007) White spot syndrome virus in cultured shrimp:
a review. Aquac Res 38:13391354. https://doi.org/10.1111/j.1365-2109.2007.01827.x
Saptiani G, Sidik AS, Ardhani F, Hardi EH (2020a) Response of hemocytes profile in the black tiger shrimp
(Penaeus monodon)againstVibrio harveyi induced by Xylocarpus granatum leaves extract. Vet World 13:
751. https://doi.org/10.14202/vetworld.2020.751-757
Saptiani G, Asikin AN, Ardhani F (2020b) Sonneratia alba extract protects the post larvae of tiger shrimp
Penaeus monodon against Vibrio harveyi and Sapro legnia sp. E3S Web Conf 147:01004. https://doi.org/10.
1051/e3sconf/202014701004
1618 Aquaculture International (2021) 29:1591–1620
Sarkheil M, Sourinejad I, Mirbakhsh M, Kordestani D, Johari SA (2016) Application of silver nanoparticles
immobilized on TEPA-Den-SiO2as water filter media for bacterial disinfection in culture of Penaeid shrimp
larvae. Aquac Eng 74:1729. https://doi.org/10.1016/j.aquaeng.2016.05.003
Satish L, Santhakumari S, Gowrishankar S, Pandian SK, Ravi AV, Ramesh M (2017) Rapid biosynthesized
AgNPs from Gelidiella acerosa aqueous extract mitigates quorum sensing mediated biofilm formation of
Vibrio speciesan in vitro and in vivo approach. Environ Sci Pollut Res 24:2725427268. https://doi.org/
10.1007/s11356-017-0296-4
Selvam R, Marimuthu S, DSouza P (2020) Impact of phytocee, a phytogenic feed additive on survivability of
Litopenaeus vannamei shrimps under WSSV and salinity stress challenges. Int J Fisher Aquat Stud 8:261265
Selvin J, Manilal A, Sujith S, Kiran GS, Lipton AP (2011) Efficacy of marine green alga Ulva fasciata extract on
the management of shrimp bacterial diseases. Lat Am J Aquat Res 39:197204. https://doi.org/10.3856/
vol39-issue2-fulltext-1
Sengupta M, Austin S (2011) Prevalence and significance of plasmid maintenance functions in the virulence
plasmids of pathogenic bacteria. Infect Immun 79:25022509. https://doi.org/10.1128/IAI.00127-11
Sharma SK, Shankar KM, Sathyanarayana ML, Sahoo AK, Patil R, Narayanaswamy HD, Rao S (2010)
Evaluation of immune response and resistance to diseases in tiger shrimp, Penaeus monodon fed with
biofilm of Vibrio alginolyticus. Fish Shellfish Immunol 29:724732. https://doi.org/10.1016/j.fsi.2010.07.
016
Singh J, Dutta T, Kim KH, Rawat M, Samddar P, Kumar P (2018) Greensynthesis of metals and their oxide
nanoparticles: applications for environmental remediation. J Nanobiotechnol 16:84. https://doi.org/10.1186/
s12951-018-0408-4
Solís-Lucero G, Manoutcharian K, Hernández-López J, Ascencio F (2016) Injected phage-displayed-VP28
vaccine reduces shrimp Litopenaeus vannamei mortality by white spot syndrome virus infection. Fish
Shellfish Immunol 55:401406. https://doi.org/10.1016/j.fsi.2016.05.027
Srinivasan P, Ramasamy P (2009) Occurrence, Distribution and Antibiotic Resistance Patterns of Vibrio species
associated with viral diseased Shrimp of South Indian Aquaculture Environment Occurrence, Distribution
and Antibiotic Resistance Patterns of Vibrio species. Int J Agricult Sci 1:110. https://doi.org/10.9735/0975-
3710.1.2.1-10
Srinivasan R, Chaitanyakumar A, Subramanian P, Mageswari A, Gomathi A, Aswini V, Sankar AM, Ramya M,
Gothandam KM (2020) Recombinant engineered phage-derived enzybiotic in Pichia pastoris X-33 as whole
cell biocatalyst for effective biocontrol of Vibrio parahaemolyticus in aquaculture. Int J BiolMacromol 154:
15761585. https://doi.org/10.1016/j.ijbiomac.2019.11.042
Ssekatawa K, Byarugaba DK, Kato CD, Wampande EM, Ejobi F, Tweyongyere R, Nakavuma JL (2021) A
review of phage mediated antibacterial applications. Alexandria J Med 57:120. https://doi.org/10.1080/
20905068.2020.1851441
Su H, Liu S, Hu X, Xu X, Xu W, Xu Y, Li Z, Wen G, Liu Y, Cao Y (2017) Occurrence and temporal
variation of antibiotic resistance genes (ARGs) in shrimp aquaculture: ARGs dissemination from
farming source to reared organisms. Sci Total Environ 607:357366. https://doi.org/10.1016/j.
scitotenv.2017.07.040
Suebsing R, Prombun P, Srisala J, Kiatpathomchai W (2013) Loop-mediated isothermal amplification combined
with colorimetric nanogold for detection of the microsporidian Enterocytozoon hepatopenaei in penaeid
shrimp. J Appl Microbiol 114:12541263. https://doi.org/10.1111/jam.12160
Sun B, Quan H, Zhu F (2016) Dietary chitosan nanoparticles protect crayfish Procambarus clarkii against white
spot syndrome virus (WSSV) infection. Fish Shellfish Immunol 54:241246. https://doi.org/10.1016/j.fsi.
2016.04.009
Tangprasittipap A, Srisala J, Chouwdee S, Somboon M, Chuchird N, Limsuwan C, Srisuvan T, Flegel TW,
Sritunyalucksana K (2013) The microsporidian Enterocytozoon hepatopenaei is not the cause of white feces
syndrome in whiteleg shrimp Penaeus (Litopenaeus) vannamei. BMC Vet Res 9:139. https://doi.org/10.
1186/1746-6148-9-139
Tello-Olea M, Rosales-Mendoza S, Campa-Córdova AI et al (2019) Gold nanoparticles (AuNP) exert
immunostimulatory and protective effects in shrimp (Litopenaeus vannamei)againstVibrio
parahaemolyticus. Fish Shellfish Immunol 84:756767. https://doi.org/10.1016/j.fsi.2018.10.056
Thammatinna K, Egan ME, Htoo HH et al (2020) A novel vibriophage exhibits inhibitory activity against host
protein synthesis machinery. Sci Rep 10:114. https://doi.org/10.1038/s41598-020-59396-3
Thiruppathiraja C, Kumar S, Murugan V, Adaikkappan P, Sankaran K, Alagar M (2011) An enhanced immuno-
dot blot assay for the detection of white spot syndrome virus in shrimp using antibody conjugated gold
nanoparticles probe. Aquaculture 318:262267. https://doi.org/10.1016/j.aquaculture.2011.06.008
Van Hyning DL, Klemperer WG, Zukoski CF (2001) Silver nanoparticle formation: Predictions and verification
of the aggregative growth model. Langmuir 17:31283135. https://doi.org/10.1021/la000856h
1619Aquaculture International (2021) 29:1591–1620
Vaseeharan B, Ramasamy P, Chen JC (2010) Antibacterial activity of silver nanoparticles (AgNps) synthesized
by tea leaf extracts against pathogenic Vibrio harveyi and its protective efficacy on juvenile Feneropenaeus
indicus. Lett Appl Microbiol 50:352356. https://doi.org/10.1111/j.1472-765X.2010.02799.x
Velmurugan S, Jerin N, Babu MM, Bindhu F, Dhas SA, Citarasu T (2015) Screening and characterization of
antiviral compounds from Enteromorpha flexuosa against white spot syndrome virus (WSSV) and its
in vivo influence on Indian white shrimp Fenneropenaeus indicus. Aquac Int 23:6580. https://doi.org/10.
1007/s10499-014-9798-y
Vidal J, Aderaldo M, Pessôa MNDC, Santos FLD, Mendes PDP, Mendes MS (2018) Probiotic potential of
Bacillus cereus against Vibrio spp. in post-larvae shrimp. Rev Caatinga 31:495503. https://doi.org/10.1590/
1983-21252018v31n226rc
Vinay TN, Girisha SK, D'souza R, Jung MH, Choudhury TG, Patil SS (2016) Bacterial biofilms as Oral Vaccine
Candidates in Aquaculture. India J Comp Microbiol Immunol Infect Diseas 37:5762. https://doi.org/10.
5958/0974-0147.2016.00011.8
Vinay TN, Ray AK, Avunje S, Thangaraj SK, Krishnappa H, Viswanathan B, Reddy MA, Vijayan KK, Patil PK
(2019) Vibrio harveyi biofilm as immunostimulant candidate for high-health pacific white shrimp, Penaeus
vannamei farming. Fish Shellfish Immunol 95:498505. https://doi.org/10.1016/j.fsi.2019.11.004
Walker PJ, Mohan CV (2009) Viral disease emergence in shrimp aquaculture: origins, impact and the effective-
ness of health management strategies. Rev Aquac 1:125154. https://doi.org/10.1111/j.1753-5131.2009.
01007.x
Wang H, Wang C, Tang Y, Sun B, Huang J, Song X (2018) Pseudoalteromonas probiotics as potential
biocontrol agents improve the survival of Penaeus vannamei challenged with acute hepatopancreatic
necrosis disease (AHPND)-causing Vibrio parahaemolyticus. Aquaculture 494:3036. https://doi.org/10.
1016/j.aquaculture.2018.05.020
Weinbauer MG (2004) Ecology of prokaryotic viruses. FEMS Microbiol Rev 28:127181. https://doi.org/10.
1016/j.femsre.2003.08.001
Wiyoto W, Sukenda S, Harris E, Nirmala K, Djokosetiyanto D, Ekasari J (2017) The effects of sediment redox
potential and stocking density on Pacific white shrimp Litopenaeus vannamei production performance and
white spot syndrome virus resistance. Aquac Res 48:27412751. https://doi.org/10.1111/are.13107
Wu CC, Lin CL, Huang CY, Hsieh S, Liu CH, Hsieh SL (2019) α-Phellandrene enhances the immune response
and resistance against Vibrio alginolyticus in white shrimp (Litopenaeus vannamei). Fish Shellfish Immunol
84:11081114. https://doi.org/10.1016/j.fsi.2018.11.013
Yeh ST, Lee CS, Chen JC (2006) Administration of hot-water extract of brown seaweed Sargassum duplicatum
via immersion and injection enhances the immune resistance of white shrimp Litopenaeus vannamei. Fish
Shellfish Immunol 20:332345. https://doi.org/10.1016/j.fsi.2005.05.008
Yi G, Qian J, Wang Z, Qi Y (2003) A phage-displayed peptide can inhibit infection by white spot syndrome
virus of shrimp. J Gen Virol 84:25452553. https://doi.org/10.1099/vir.0.19001-0
Yoshida T, Kruger R, Inglis V (1995) Augmentation of non-specific protection in African catfish, Clarias
gariepinus (Burchell), by the long-term oral administration of immunostimulants. J Fish Dis 18:195198.
https://doi.org/10.1111/j.1365-2761.1995.tb00278.x
Yu P, Wang T, Ye H, Shan H, Ma S (2020) Isolation and identification of pathogenic Vibrio spp. retrieved from
diseased Litopenaeus vannamei and beneficial role of some functional probiotic bacteria for control. Aquac
Int 28:14031420. https://doi.org/10.1007/s10499-020-00530-3
Yuan L, Zhang X, Xiao N, Dai L, Chen W, Jia C, Zhao R, Hemmingsen SM, Dai H (2006) Identification of a
WSSV neutralizing scFv antibody by phage display technology and in vitro screening. Dis Aquat Org 72:
9399. https://doi.org/10.3354/dao072093
Zhang QL, Liu S, Li J, Xu TT, Wang XH, Fu GM, Li XP, Sang SW, Bian XD, Hao JW (2018) Evidence for
cross-species transmission of covert mortality nodavirus to new host of Mugilogobius abei. Front Microbiol
9:1447. https://doi.org/10.3389/fmicb.2018.01447
Zhou H, Gai C, Ye G, An J, Liu K, Xu L, Cao H (2019) Aeromonas hydrophila, an Emerging Causative Agent
of Freshwater-Farmed Whiteleg shrimp Litopenaeus vannamei. Microorganisms 7(10):450. https://doi.org/
10.3390/microorganisms7100450
Zoroddu MA, Medici S, Ledda A, Nurchi VM, Lachowicz JI, Peana M (2014) Toxicity of nanoparticles. Curr
Med Chem 21:38373853. https://doi.org/10.2174/0929867321666140601162314
Publishersnote Springer Nature remains neutral with regard to jurisdictional claims in published maps
and institutional affiliations.
1620 Aquaculture International (2021) 29:1591–1620
... Efforts should be focused on promoting sustainable and responsible aquaculture practices that prioritize the health and welfare of shrimp, minimize the use of antibiotics, and ensure the safety of the final food products. Continued research and the adoption of alternative disease management strategies are essential for the long-term sustainability of the shrimp aquaculture industry [16]. ...
... Controlling diseases in shrimp aquaculture is crucial for industry sustainability and growth [16]. Pathogenic bacteria and viruses can cause financial losses and impact shrimp growth [38,39]. ...
Article
Full-text available
The study aimed to address the recurring outbreaks of microbial diseases in shrimp aquaculture in Bangladesh the study focused on the utilization of bacteriophages and non-pathogenic Vibrio. The bacteriophages were isolated from sewage water sample collected from shrimp farm, hatchery, and the JUST campus. The bacte-riophages were tested for their ability to infect different Vibrio strains in order to assess their bacteriolytic activity. Non-pathogenic Vibrio strains were obtained from suspected diseased isolates collected from the southwestern region of Bangladesh through PCR amplification. In laboratory tests, the bacteriophages successfully infected 91 % of the tested Vibrio strains (19 out of 21 strains). In the experimental unit, shrimp treated with phage prophylaxis and phage treatment demonstrated notable protection against AHPND and was able to survive a deadly bacterial challenge. A total of 35 suspected diseased isolates were tested, and PCR amplification revealed 6 non-pathogenic Vibrio strains. In field trials, cultured bacteriophages were applied at a concentration of 1.5×10 6 PFU/ml, while non-pathogenic Vibrio was applied at 5×10 5 CFU/ml. The trials showed increased protection against infections and no severe deaths during the adaptive research phase. The cultured shrimp were analyzed morphologically and showed a muscle gut ratio greater than 4:1. No abnormal deformities were observed in their appendages or overall body, suggesting their overall health and well-being. The bacteriological tests conducted on the shrimp samples (application of bacteriophages and non-pathogenic Vibrio) revealed that 18 % of them were infected with bacteria, primarily Vibrio cholerae, Vibrio parahaemolyticus, and other bacterial species. Despite this, the infections did not lead to a disease outbreak; PCR amplification showed negative results for AHPND, White Spot Syndrome Virus (WSSV), and Enterocytozoon hepatopenaei (EHP). The results highlight the potential of using bacteriophages and non-pathogenic Vibrio as a sustainable solution for preventing and controlling microbial diseases in shrimp aquaculture. Furthermore, this study will contribute valuable insights into the development of alternative strategies to combat antibiotic resistance and promote the growth of the shrimp industry in Bangladesh.
... Shrimp farming has developed considerably in many nations worldwide and has become competitive to maintain sustainable and extensive shrimp production in line with market demand (Macusi et al., 2022). Infectious diseases caused by bacteria and viruses are one of the significant challenges in the shrimp industry and have been reported to be associated with poor water quality (Alfiansah et al., 2018;Seethalakshmi et al., 2021). Water quality is essential to maintaining a sustainable shrimp farm operation, which biotic and abiotic environmental factors can impact. ...
... Antibiotic therapy, initially a huge success in treating diseases in aquaculture products, has become a contentious issue due to the risk of spreading antibioticresistant bacteria and concerns about the food safety of aquaculture products (Seethalakshmi et al., 2021). Thus, using prebiotics and probiotics in conjunction with dietary supplements is a viable and ecologically friendly alternative to antibiotics to combat pathogenic agents (Singh et al., 2021). ...
Article
Full-text available
Aims: Prebiotics and probiotics profoundly enhance water quality and shrimp development to tackle infectious disease in shrimp farming. This study evaluated the impact of prebiotics and probiotics treatments in water by assessing the physicochemical properties and bacterial communities in local shrimp ponds. Methodology and results: Water was collected from shrimp pond 1 (SP1), treated with prebiotics and probiotics, and shrimp pond 2 (SP2), treated with only prebiotics. The physicochemical parameters of water from two shrimp ponds were measured, including pH, dissolved oxygen (DO), ammonia concentration and temperature. The total environmental DNA (eDNA) was extracted from the water samples and sequenced using amplicon sequencing targeting the full length of the 16S rRNA gene region via the Oxford Nanopore Technology Flongle. The water quality analysis indicated that SP1 had better water quality than SP2 for shrimp aquaculture. The dominant phyla in both shrimp ponds were Proteobacteria and Bacteroidota. SP1 samples had unique microbiota at the phylum level, including Bdellovibrionota, Firmicutes A, Patescibacteria and unclassified Rhizobiales, Saprospiraceae, Vulcanococcus and HIMB114 at the genus level. The alpha-and beta-diversity showed insignificant differences in microbiota composition between SP1 and SP2 (p-value>0.05). Conclusion, significance and impact of study: Research findings demonstrated that the probiotic-treated shrimp pond (SP1) had better water quality and more diverse microbial communities than the shrimp pond that was not treated with probiotics (SP2).
... Drug resistance and bioaccumulation in aquatic life forms are just two of the environmental issues that have arisen from this scenario (Yaqub et al., 2022). Probiotic use has recently become well-known as a trustworthy substitute that could reduce the overuse of antibiotics in aquaculture (Olmos et al., 2020;Seethalakshmi, 2021). ...
... V. parahaemolyticus is one of the well-known opportunistic bacteria in the marine aquaculture industry, and is associated with the emergence of the fatal infection of AHPND (acute hepatopancreatic necrosis disease) [25]. One of the effective strategies to increase the resistance against vibriosis infection and boost other physiological processes in shrimps is the administration of OAs in their diet [11,21]. ...
Article
Full-text available
Tartaric acid (TA) is an organic acid whose properties in aquaculture have not yet been comprehensively studied. In the current research, the effect of dietary TA on growth indices, gut microbiota, the level of digestive enzymes, antioxidant and immunological markers, and survival rate following immersion challenge with Vibrio parahaemolyticus (14 days) in Litopenaeus vannamei were investigated. To achieve this, 600 shrimp (3.26 ± 0.05 g) were tested with pellets supplemented with five distinct concentrations of TA including 0 (TA0), 2.5 (TA2.5), 5 (TA5), 7.5 (TA7.5), and 10 g/kg (TA10) for 56 days. The results showed that the growth performance, feed utilization, gut lactic acid bacteria (LAB) count, and activity of digestive enzymes were markedly elevated in the groups receiving diets incorporated with 5 and 7.5 g/kg of TA. The highest total hemocyte count (THC), hyaline cell (HC), and semi-granular cell (SGC) counts were detected in shrimp fed with the TA7.5 diet. Hemolymph immune responses including LYZ (lysozyme), alkaline phosphatase (AKP), acid phosphatase (ACP), and phenol oxidase (PO) activities were significantly enhanced in all TA-treated groups. Dietary TA7.5 significantly boosted all antioxidant enzymes. In addition, malondialdehyde (MDA) content illustrated a significant decrease in shrimp fed with diets supplemented with 2.5–10 g/kg TA when compared with specimens fed with TA0. The survival rate following the immersion challenge with Vibrio parahaemolyticus markedly increased in all shrimp treated with 2.5–10 g/kg TA compared to TA0, irrespective of the dosage. However, the dietary inclusion of TA7.5 resulted in the highest survival rate. Based on the outcomes, dietary TA, especially at the concentration of 7.5 g/kg, is proposed to promote the growth performance and immunological indicators of L. vannamei.
... Nanotechnology aspects have also been implemented against AHPND. Various nanoparticles such as silver and gold nanoparticles have also been reported to show antimicrobial property against AHPND challenge [151][152][153]. Given that AHPND is a recently developing disease, bio-surveillance therapy can be used which involves constant monitoring of microbial composition in rearing water from both larvae grown with or without antibiotics and to investigate the presence of pathogenic microbial communities in case of mortality rate at a significant level [154]. ...
... For example, ~$4 billion in losses were recorded during the period 2009-2018 in the Asian shrimp industry (Asche et al., 2021;Shinn et al., 2018). To control this so-called disease crisis (Doyle, 2016), the industry has introduced strategies to identify, monitor and control viruses, bacteria and parasites (Flegel and Alday-Sanz, 1998;Seethalakshmi et al., 2021), and to enhance the crustacean immune system (Aweya et al., 2021;Kulkarni et al., 2021;Nguyen et al., 2018). Like most multicellular organisms, crustaceans are metaorganisms (or holobionts) that consist of a host and its associated microbial community (microbiome) (McFall-Ngai et al., 2013). ...
Article
Full-text available
Aquaculture is a growing global food production sector that aims to meet the increasing demand for dietary protein. Crustaceans are an important and predominantly high-priced aquaculture segment that could support the transfer of sustainable new technologies to other sectors. Areas of interest include disease management and compound feeds, both of which have the potential to improve both the profitability and sustainability of aquaculture. Modern compound feeds are largely composed of fishmeal and/or terrestrial plant materials, the production of which is unsustainable, leading to the depletion of finite resources. Insects are a promising protein-rich alternative to fishmeal that can reduce the environmental footprint of aquafeeds and crustacean aquaculture. First research data have shown that insect meal has a favourable nutritional composition with positive health effects, and is environmentally sustainable with a strong economic potential, particularly supporting circular economy by valorising otherwise unused side-streams. In this article, we discuss the current state of crustacean aquaculture and highlight the benefits of insect meal compared to today’s compound aquafeeds in terms of health and growth-promoting properties as well as environmental benefits. We then consider the molecular mechanisms that confer immunity and disease resistance in crustacean aquaculture and show how insect feeds can support disease management and thus consumer health. Next, we assess the environmental sustainability of crustacean aquaculture and insect farming, the legal framework for insect-based feeds and consumer acceptance issues. Lastly, we identify research gaps, socioeconomic considerations and the potential of insect-based sustainable crustacean aquaculture for the global market.
Article
Full-text available
Biofilm (BF) can give rise to systemic infections, prolonged hospitalization times, and, in the worst case, death. This review aims to provide an overview of recent strategies for the prevention and destruction of pathogenic BFs. First, the main phases of the life cycle of BF and maturation will be described to identify potential targets for anti-BF approaches. Then, an approach acting on bacterial adhesion, quorum sensing (QS), and the extracellular polymeric substance (EPS) matrix will be introduced and discussed. Finally, bacteriophage-mediated strategies will be presented as innovative approaches against BF inhibition/destruction.
Article
Crustins represent one type of antimicrobial peptides (AMPs) that are key components of the innate immune process of crustaceans. This study successfully identified a novel crustin-like peptide, EcCrustin2, in ridgetail white prawn, Palaemon carinicauda (formerly Exopalaemon carinicauda). EcCrustin2 was found to be 1082 bp in length, with a 378 bp open reading frame (ORF) encoding 125 amino acids. The deduced amino acid sequence of EcCrustin2 exhibited characteristics of crustins in crustacean, including a Cys-rich region at the N-terminus as well as a whey acidic protein domain at the C-terminus. Phylogenetic analysis revealed that the EcCrustin2 was first clustered with Type I crustins, then with other crustins. Expression of EcCrustin2 was mainly detected in immune tissues, including hemocytes, gill and stomach. The expression level of EcCrustin2 was also significantly up-regulated after being exposed to lipopolysaccharide (LPS), lipoteichoic acid (LTA), Vibrio parahaemolyticus and Staphylococcus aureus. EHP infection could also induce EcCrustin2 expression in P. carinicauda. Knockdown of EcCrustin2 with siRNA increased the mortality of V. parahaemolyticus challenged shrimp. Finally, the recombinant EcCrustin2 protein was obtained and demonstrated a wide spectrum of antibacterial activity in vitro. These results indicated that EcCrustin2 takes part in the immune response against bacteria and EHP infection.
Article
Actinomycetes, as the main producers of a variety of active metabolites and enzymes, have received extensive attention in aquaculture. An actinomycete had been isolated from Haizhou Bay and been identified by morphological analysis and 16S rRNA sequencing. Results showed that the actinomycete had the highest similarity (99.65%) with Nocardiopsis sp. and was named strain E10. Strain E10 produced an exo-enzyme with proteinase effect that showed strong antibacterial activity against Vibrio anguillarum. This strain E10 was tested as a probiotic for the culture of Exopalaemon carinicauda. After having been fed with a diet supplemented with strain E10 for 30 days, the final body weight (Wt), weight gain rate (WGR), special growth rate (SGR), survival rate (SR) and digestive enzymes (chymotrypsin, α-amylase and lipase) of E. carinicauda in all experimental groups showed no significant differences ( P > 0.05). However, the antioxidant enzymes (total superoxide dismutase, catalase and peroxidase) and the non-specific immune-related enzymes (acid phosphatase, alkaline phosphatase and lysozyme) in the treatment groups increased significantly ( P < 0.05) compared with the control group. The cumulative mortality of the treatment groups (35.56% in 5 × 109 CFU/100 g) was significantly lower than that of the control treatment (73.33%) ( P < 0.05) post challenge with V. anguillarum for 14 days. The results indicated that strain E10 had no significant effect on the growth, but a significant improvement on the immunity of E. carinicauda. This study provides the data for ecological aquaculture of E. carinicauda.
Article
Full-text available
Background: For over a decade, resistance to newly synthesized antibiotics has been observed worldwide. The challenge of antibiotic resistance has led to several pharmaceutical companies to abandon the synthesis of new drugs in fear of bacteria developing resistance in a short period hence limiting initial investment return. To this effect, alternative approaches such as the use of bacteriophages to treat bacterial infections are being explored. This review explores the recent advances in phage-mediated antibacterial applications and their limitations. Methods: We conducted a comprehensive literature search of PubMed, Lib Hub and Google Scholar databases from January 2019 to November 2019. The search key words used were the application of bacteriophages to inhibit bacterial growth and human phage therapy to extract full-text research articles and proceedings from International Conferences published only in English. Results: The search generated 709 articles of which 95 full-text research articles fulfilled the inclusion guidelines. Transmission Electron Microscopy morphological characterization conducted in 23 studies registered Myoviruses, Siphoviruses, Podoviruses, and Cytoviruses phage families while molecular characterization revealed that some phages were not safe to use as they harbored undesirable genes. All in vivo phage therapy studies in humans and model animals against multidrug-resistant (MDR) bacterial infection provided 100% protection. Ex vivo and in vitro phage therapy experiments exhibited overwhelming results as they registered high efficacies of up to 100% against MDR clinical isolates. Phage-mediated bio-preservation of foods and beverages and bio-sanitization of surfaces were highly successful with bacterial growth suppression of up to 100%. Phage endolysins revealed efficacies statistically comparable to those of phages and restored normal ethanol production by completely eradicating lactic acid bacteria in ethanol fermenters. Furthermore, the average multiplicity of infection was highest in ex vivo phage therapy (557,291.8) followed by in vivo (155,612.4) and in vitro (434.5).
Article
Full-text available
Shrimp aquaculture is a growing food producing industry which historically has faced the economic consequences of diverse epidemics. Silver nanoparticles (AgNPs) offer a novel and innovative alternative to traditional drugs (i.e. antibiotics) to cope with infectious diseases in human medicine and veterinary, due their application flexibility and broad spectrum activity against microbes. Herein, we summarize the research advances and fundamentals in the use of AgNPs as prophylactics and therapeutic agents against bacteria and viruses affecting cultured shrimp. We also discuss the major concerns about the toxicity and biosecurity of these nanomaterials for shrimp and other marine organisms, as well as the major challenges and perspectives for a feasible large-scale administration and applications of AgNPs as antimicrobials in shrimp farming.
Article
Full-text available
Aquatic animal diseases are one of the major limiting factors in aquaculture development, with disease emergence forecast to increase with global change. However, in order to treat increasing diseases in a context of global emergence of antimicrobial resistance and strengthening regulations on antimicrobial use, sustainable alternatives are urgently needed. The use of plant supplements to increase fish immunity and disease resistance has gained much popularity within the last decades. The use of functional supplements, such as plants, can also improve growth and feed assimilation, contributing to a better optimization of aquaculture resources (e.g. fish meal inclusion). We conducted a systematic review and meta-analysis in order to identify the research gaps in the use of plant-enriched diets in fish aquaculture and estimate, for the first time, the overall efficacy of plant-enriched diets on fish growth, immunity and disease resistance as well as the effect of intrinsic parameters (fish trophic level, type of plant material, dosage, treatment duration and pathogen species) on the treatment efficacy. We found that plant-enriched diets significantly enhanced growth, immunity and disease survival of treated fish, regardless of the fish trophic level, treatment duration and type of material used. We also show that plant supplements are a versatile alternative that can benefit different aquaculture sectors (from small-scale fish farmers to intensive productions). Finally, we observed that studies need to improve the information reported about the plant material used (e.g. origin, identification, chemical composition), in order to allow the comparison of different experiments and improve their repeatability.
Article
Full-text available
The high level of attack of both infectious and non-infectious diseases results in low production in giant tiger prawn (Penaeus monodon) in North Kalimantan's traditional coastal aquaculture ponds. One of the most severe pathogens of concern is Vibrio harveyi. The present study investigates whether Sonneratia alba fruit extract inhibits V. harveyi infection challenging giant tiger prawn postlarvae through a feed of Artemia salina. Three different doses of S. alba extract (15 ppm, 20 ppm, and 25 ppm), and one control (0 ppm) were used in this study. The extract was used to enrich A. salina as feed for giant tiger prawn postlarvae, which were then challenged with V. harveyi. The experimental methods involved a completely randomised design (CRD) with three replications. Among the four groups, the highest survival rate (78.33%) was observed in the treatment using 20 ppm of S. alba extract, and this group exhibited significantly (P>0.05) better survival and inhibition of V. harveyi infection in giant tiger prawn.
Article
Full-text available
The practice and development of the culture of commercially important penaeid shrimp results in the occurrence of infectious and non-infectious diseases worldwide. Most of the diseases are caused by the opportunistic microorganisms which are part of the microflora and fauna of the penaeid shrimp. Once the pathogens get a favourable condition, it will cause diseases to the host organisms. Most of the organisms are ubiquitous and are found and reported all over the cultured area in the world. The pathogens are the bacteria, viruses, parasites and protozoans. Viruses are the most important disease-causing agents in penaeid shrimps. The penaeid viruses are widely spread in geographical areas of shrimp culture. The shipment of broodstock and post larvae from one geographical region to another region often results in spreading of viral diseases. The penaeid viruses are the Whispovirus, white spot syndrome virus (WSSV), Penaeus monodon baculovirus (monodon baculovirus), infectious hypodermal and haematopoietic necrosis virus (IHHNV), infectious myonecrosis virus (IMNV), Taura syndrome virus (TSV), yellow head virus (YHV), white tail disease (WTD), covert mortality nodavirus (CMNV), Laem–Singh virus (LSNV) and shrimp haemocyte iridescent virus (SHIV). The review examines and highlights the aquaculture penaeid shrimp viral diseases in detail and concludes the need and importance of severe disease surveillance of the global countries through networking and coordination to safeguard the aquaculture practice for our future generation.
Article
Full-text available
This study proposed that phage-enriched artemia could be a useful tool for transferring phage into the cultured fish (larvae or adult) as a feed, and introduce mode of phage administration and its safety in concern of tissue adaptation for efficient phage therapy in aquatic animals. First, whether Edwardsiella tarda phage (ETP-1) could attach or ingest by the artemia and optimum time period for the ETP-1 enrichment with artemia were investigated. ETP-1 dispersion, abundance and persistency, and zebrafish immune transcriptional responses and histopathology were evaluated after feeding the fish with ETP-1-enriched artemia. Hatched artemia nauplii (36 h) were enriched with 1.90 × 1011 PFUmL−1 of ETP-1, and maintained at 25 °C. The highest enrichment level was obtained after 4 h (3.00 × 109 PFUmL−1), and artemia were alive and active similar to control for 8 h. ETP-1 disseminated dose dependently to all the tissues rapidly (12 h). However, when feeding discontinued, it drastically decreased at day 3 with high abundance and persistency in the spleen (1.02 × 103) followed by the kidney (4.00 × 101) and the gut (1 × 101 PFUmL−1) for highest ETP-1-enriched artemia dose. In contrast, during continuous delivery of ETP-1-enriched artemia, ETP-1 detected in all the tissues (at day 10: gut; 1.90 × 107, kidney; 3.33 × 106, spleen; 5.52 × 105, liver; 6.20 × 104 PFUmL−1mg−1 tissues). Though the phage abundance varied, results indicated that oral fed ETP-1-enriched artemia disperse to the neighboring organs, even the absence of host as phage carrier. Non-significant differences of immune transcriptional and histopathology analysis between ETP-1-enriched artemia fed and controls suggest that no adverse apparent immune stimulation in host occurred, and use of ETP-1 at 1011 PFUmL−1 was safe. With further supportive studies, live artemia-mediated phage delivery method could be used as a promising tool during phage therapy against pathogenic bacteria to control aquatic diseases.
Article
The microbiome of the host and its surroundings play a vital role in its health and well‐being. Unlike the terrestrial organisms that maternally acquire its microbiome, the aquatic species mainly get colonized by the microorganisms in its aquatic surrounding and are exposed to a wide variety of microbial community based on the type of aquatic environment the host inhabits. This review is focused on the aquaculture and shrimp microbiome and factors that influence its microbiome such as prebiotics, probiotics, synbiotics, diet, stress conditions, frequency and type of antibiotics used, host physiological conditions and developmental stages. This review also casts light on the role of the microbiome in enhancing the shrimp health, immune response, microbial colonization, and the effects of the biofloc system on shrimp and aquaculture microbiome. Moreover, beneficial microbes can be a safer alternative to harmful antibiotics used in aquaculture, which can thereby prevent the emergence of superbugs and also enhance the production rate. A proper understanding of the interactions between the host and its microbiome can help us to modulate and manipulate the aquaculture microbiome to enhance the health of aquatic organisms, which ensures the growth of the aquaculture industry. Therefore, the treatment strategies should be targeted towards the modulation of shrimp and aquaculture microbiome, which acts as beneficial partners to overcome the challenges confronted by the aquaculture sector.
Article
Immunostimulation is a novel method and a promising development in aquaculture. Products derived from plants exhibit various biological activities. In this study, the hot-water extract isolated from fresh cacao (Theobroma cacao) pod husks (CPHs) was administered by injection to evaluate cellular signaling pathways of innate immunity, the immunostimulating potential, disease resistance, and hypothermal tolerance of white shrimp, Litopenaeus vannamei. Results showed significant increases in the total hemocyte count, semigranular cells, granular cells, phenoloxidase activity, and respiratory bursts (RBs) of hemocytes per unit of hemolymph at 1 day, and in phagocytic activity toward and the clearance efficiency of Vibrio alginolyticus at 1–3 days after shrimp were injected with fresh CPH extract at 40 μg shrimp⁻¹. However, only RBs per hemocyte had significantly decreased at 1 day after the injection. All immune parameters had returned to control levels by 3 days after receiving fresh CPH extract except for RBs, phagocytic activity, and the clearance efficiency, which had returned to control values by 7 days. Furthermore, at 1 day after the injection, the peroxinectin, prophenoloxidase (proPO) II, toll-like receptors (TLR) 3, signal transducer and activator of transcription (STAT), and crustin in shrimp receiving fresh CPH extract at 20 μg shrimp⁻¹, and the lipopolysaccharide and β-1,3-glucan-binding protein, proPO II, TLR1, and STAT in shrimp receiving fresh CPH extract at 40 μg shrimp⁻¹ were significantly higher than those of shrimp receiving saline. After injecting fresh CPH extract at 10–40 μg shrimp⁻¹ and 40 μg shrimp⁻¹, the mortality of shrimp challenged with V. alginolyticus and exposed to 14 °C for 96 h significantly decreased, respectively. These results suggest that fresh CPH extract can be used as an immunostimulant and a physiological regulator for shrimp through injection administration to enhance immunological and physiological responses, which can elevate the resistance against V. alginolyticus and tolerance against hypothermal stress in L. vannamei.